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1. Zusammenfassung 
 
Regeneration von Geweben im Allgemeinen und von Gliedmaßen im Speziellen sind sehr selten 
unter Vertebraten. Eine Ausnahme bildet der amphibische Schwanzlurch Notophthalmus 
viridescens viridescens, welcher ein aussergewöhnliches regeneratives Potenzial im adulten 
Stadium besitzt. Nach Amputation einer Gliedmaße, unabhängig von ihrer Lokalisation entlang 
der proximodistalen Achse, wird das entfernte Gewebe wieder aufgebaut. Dieser Prozess beginnt 
mit einer lokalen Anhäufung von Mesenchym-ähnlichen Zellen, welche als Blastema bezeichnet 
werden. Diese Zellen zeigen Stammzellen-ähnliche Eigenschaften und ersetzen das verlorene 
Gewebe. Das Ziel dieser Arbeit war es den Ursprung dieser blastemalen Zellen zu definieren. 
Die meisten Studien über blastemale Vorläufer benutzen Muskelzellen. Diese synzytialen Zellen, 
vor allem jene nahe der Amputationsstelle, werden mononukleär und beginnen zu proliferieren, 
ein Ereignis, welches als Dedifferenzierung bezeichnet wird. Bis heute sind die grundlegenden 
Mechanismen der Dedifferenzierung nicht gänzlich verstanden. In dieser Arbeit untersuchen wir 
die Beteiligung von Histonmodifizierungen und ihrer katalytischen Enzyme an der 
Dedifferenzierung. 
 
Histon Methylierungen wurden an früh sich regenerierenden Gliedmaßengeweben untersucht, um 
Muster zu finden, welche die Dedifferenzierung charakterisieren. Das Hauptaugenmerk lag auf 
Histon H3 Lysin 9 Methylierung, weil diese Modifikation generell mit inaktiven und daher 
transkriptionell ruhigem Chromatin einhergeht. Durch Vergleich verschiedener früher Zeitpunkte 
der Gliedmaßenregeneration wollten wir untersuchen ob signifikante Unterschiede in Bezug auf 
Demethylierung dieser Markierung entstehen. Unsere Daten geben Hinweis darauf, dass 
innerhalb der ersten 10 Tage der Gliedmaßenregeneration ein signifikanter Verlust von Histon 
H3 Lysin 9 Methylierung auftritt. 
 
In einem zweiten Ansatz benutzten wir den Inhibitor Trichostatin A (TSA) um die Beteiligung 
von Histon-Deacetylasen während der Dedifferenzierung zu untersuchen. In vitro kultivierte 
Molch und Säugetier Muskelzellen wurden unterschiedlichen Konzentrationen von und 
Inkubationszeiten mit TSA ausgesetzt. Die Resultate deuten darauf hin, dass TSA eine 
Veränderung induziert, welche die Muskelzellen zur Fragmentierung anregt. Jedoch waren ihre 
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Spaltprodukte weder mononucleär noch konnte ein Wiedereintritt in den Zellzyklus beobachtet 
werden.
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2. Abstract 
 
Regeneration of tissues in general and limb regeneration in particular is a very rare event among 
adult vertebrates. An exception is the amphibian urodele Notophthalmus viridescens viridescens 
who displays a remarkable regenerative potential even as an adult. After amputation of the limb, 
independent of the location along the posterio-distal axis, the removed tissue is rebuilt. This 
process is initiated by the local accumulation of mesenychmal like cells, referred to as blastema. 
These cells exhibit stem cell-like properties and give rise to the lost tissue.  The emphasis of this 
work was to find out the origin of these blastemal cells. 
Most studies of blastemal progenitors use muscle cells. These syncytial cells become 
mononucleated and start to proliferate next to the amputation site, an event termed 
dedifferentiation. To date, the underlying mechanisms of dedifferentiation are not fully 
understood. In this work we investigated the involvement of histone modifications and their 
catalytic enzymes during dedifferentiation.  
 
Histone methylation marks were analysed on early regenerating limb tissues to find patterns that 
characterise dedifferentiation. We focused on histone H3 lysine 9 methylation because this mark 
is generally associated with inactive and thus transcriptionally silent chromatin. By comparing 
different early time-points during limb regeneration we wanted to investigate if significant 
changes arise in terms of de-methylation. Our data indicate that within the first 10 days of limb 
regeneration a significant loss of histone H3 lysine 9 methylation occurs.  
 
In a second approach we used the small molecule inhibitor Trichostatin A (TSA) to investigate 
the involvement of histone deacetylases during dedifferentiation. In vitro cultured newt and 
mammalian myotubes were exposed to various concentrations and incubation times of TSA. Our 
results indicate that TSA induces an alteration, which forces cultured myotubes to undergo 
fragmentation. However, their progeny were neither mononucleated nor could cell cycle re-entry 
be observed. 
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3. Introduction 
 
3.1 Newts 
 
Newts belong to the family of salamanders although they exhibit several specific characteristics. 
One difference between newts and the other members of the salamander family is their complex 
life cycle. The development of newts comprises three distinct stages separated by two complete 
metamorphoses. To date, three different species of newts are used in experimental biology: The 
red spotted newt Notophthalmus viridescens viridescens, from North America, the Iberian newt, 
Pleurodeles waltl and the Japanese newt, Cynops pyrroghaster.  
 
3.1.1 Notophthalmus viridescens viridescens 
 
Notophthalmus viridescens viridescens (N. v. viridescens), the red spotted newt, belongs to the 
species of the eastern newt (Notophthalmus viridescens). The generic name Notophthalmus 
originates from the Greek and is composed of notos, for back, and ophatalmos, for eyes. This 
refers to the typical eye-like red spots outlined in black on the back of the adults of N.v. 
viridescens the nominate form of the subspecies. Viridescens is Latin and points out the greenish 
body colour of most specimen. Four recognised subspecies exist within the species of N. 
viridescens: N. v. viridescens (Red-spotted newt), N. v. dorsalis (Broken-striped newt), N. v. 
louisianensis (Central newt) and N. v. piaropicola (Peninsula newt).  
 
 
3.1.2 Habitat 
 
The natural habitat of N. viridescens is the east coast of the nearctic region, ranging from Florida 
to the Canadian Maritime Provinces (Riemland, 2000) (see Fig. 1). 
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Figure 1. Illustration of the Distribution of 
the Four Subspecies of Notophthalmus 
viridescens 
 
(Figure taken from 
http://www.npwrc.usgs.gov; December 5, 
2007; 11:41 pm) 
 
 
 
 
 
 
3.1.3 Reproduction and life cycle 
 
Notophthalmus viridescens viridescens differ from other salamander in their 3 distinct 
developmental stages: Aquatic larval, terrestrial juvenile and semi-aquatic adult.  
 
Male newts have 3 behavioral options for inseminating females (Pinou et al., 2000-2002b). The 
most prominent in nature is an active competition for females as males normally outnumber 
females at breeding sites. Therefore, females are at first unresponsive to males who begin wooing 
with nudging the female’s cloaca and displaying by twitching and undulating their bodies. After a 
wooing-ceremony, which can last for several hours, the male newt deposits a spermatophore. 
After that he leads the female into a position so that her cloaca rests above the spermatophore to 
collect the sperm cap. 
 
The second insemination strategy is interference. Once the male embraces the female in the so-
called amplexus, rival males try to dislodge the male and replace him. Furthermore, competing 
males can assume the behaviour of breeding females during the spermatophore deposition stage. 
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Thus, by inserting himself between the courting male and female, the rival manages to deposit his 
own spermatophore (livingunderworld.org, ; Pinou et al., 2000-2002b). 
 
The third insemination tactic or hula display has mainly been observed in the laboratory. The 
female is already responsive to the male’s initial approach and does not try to evade him. 
Therefore, he simply performs an undulating dance in front of the stationary female, followed by 
the deposition of the spermatophore, as soon as the female nudges his cloacal region 
(livingunderworld.org, ; Pinou et al., 2000-2002b). 
 
Oviposition can take up to several months for a single female newt because they lay up to 400 
eggs. Furthermore, the eggs are usually deposited one by one and may be folded into a leaf for 
protection or are attached to the stems of aquatic plants. The eggs of N. viridescens are the 
smallest among salamanders. An elliptical capsule, consisting of several semipermeable, 
gelatineous layers, protects the ovum in its centre. Freshly deposited eggs have a diameter of 2.4 
to 3.6 mm and quickly swell in water (livingunderworld.org, ; Pinou et al., 2000-2002b). 
 
Larvae hatch about 20-35 days after oviposition. The hatchlings have external gills and short 
blunt front limbs while the hind legs are absent (Pinou et al., 2000-2002b). Larval newts are 
aquatic and metamorphosis into terrestrial juveniles occurs after 2-5 months. The size and the 
timing of metamorphosis into terrestrial juvenile vary between different locations and seem to be 
influenced by the competition between larvae at high larval density (Hunsinger and Lannoo, 
2007). 
 
The sexually immature, terrestrial juvenile stage is also called eft. Efts leave the aquatic 
environment and migrate into upland forests. They are diurnal and nocturnal (Hunsinger and 
Lannoo, 2007).  
Furthermore, during this terrestrial stage the newts have a brilliant colouring. This coloration is 
aposematic, meaning that it serves as warning of toxicity for potential enemies (Pinou et al., 
2000-2002a). After 2 to 7 years, depending on size and location, efts undergo a less severe 
metamorphosis into semi-aquatic adults (Hunsinger and Lannoo, 2007; livingunderworld.org). 
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Sexually mature adults are typically semi-aquatic and prefer slow moving or permanent water 
bodies. The only remnants of the bright eft coloration are 3-8 orange-red dorsolateral spots 
outlined in black. Furthermore, skin toxicity is ten times reduced in adult newts. The average life 
span of adults is 3-8 years (Hunsinger and Lannoo, 2007). 
 
The terrestrial eft stage can also be skipped. Such individuals can go through complete 
metamorphosis into adults. However, some may develop into neotenes which, in eastern newts, 
are characterised by the presence of remnants of external gills (Hunsinger and Lannoo, 2007; 
livingunderworld.org). The neotenous life cycle could be a response to suboptimal terrestrial 
conditions or ideal aquatic growth conditions such as low larval density, low risk of predation 
and high abundance of food (Pinou et al., 2000-2002b).    
 
3.1.4 Newts in research 
 
Newts in general, contribute to a wide range of findings in basic research because they offer large 
cells, nuclei and chromosomes including the particularly interesting lampbrush chromosomes in 
growing oocytes (Brockes and Kumar, 2005a). For example, the embryonic organiser was 
discovered in newt embryos by Hans Spemann and Hilde Mangold. The first visualisation of 
transcription was based on DNA from newt eggs (Miller and Beatty, 1969) and it was 
demonstrated with DNAse digestion kinetics of newt lampbrush chromosomes that one 
chromatid consists of a single DNA double helix (Gall, 1963). Furthermore, newts exhibit a 
remarkable regenerative potential even as adults. They can regenerate their limbs and tails, 
including spinal cord and sensory ganglia, upper and lower jaws, eye tissue, such as lens and 
retina, their intestine and small parts of their heart (Brockes and Kumar, 2005a; Brockes and 
Kumar, 2002). Furthermore, Parish et al. (2007) recently reported that N. v. viridescens is also 
capable of regenerating dopaminergic neurons in a Parkinson-like newt model (Parish et al., 
2007). This enormous regenerative potential of newts seems to be unique even among other 
species capable of regeneration. 
 
These different regeneration-competent organs found in the newt seem to share a common 
mechanism of plasticity of the differentiated state. Apart from this, there exists no universal 
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progenitor and different organs use different regenerating mechanisms. For example, the newt 
heart regenerates by partial reversal of differentiated cardiomyocytes into the dedifferentiated 
state. Newt cardiomyocytes in the vicinity of a removed apical region of the ventricle proliferate 
and restore the lesion. Experiments performed in vitro revealed the reactivated cardiomyocytes 
retain their morphological characteristics despite cell cycle re-entry and cytokinesis (Bettencourt-
Dias et al., 2003) . On the other hand, lens regeneration is accomplished from cells of the dorsal 
pigmented epithelium of the iris. Following lentectomy, cells at that location lose their 
pigmentation, proliferate and transdifferentiate into lens cells, which in turn build up the new 
lens. This property is exclusive the dorsal region of the iris. Ventral pigmented epithelial cells fail 
to restore the lens (Grogg et al., 2005). Limb regeneration in turn, proceeds through an initial 
step. A mesenchymal mass of cells at the distal portion of the remaining limb stump tissue, also 
referred to as blastema, originates from several differentiated progenitors. These blastemal cells 
give rise to all the lost structures and reconstitute the limb. To date, the origin of these blastemal 
cells is rather unclear (Brockes, 1997; Ferretti and Brockes, 1991; Tanaka, 2003). 
 
Although some other salamander species, such as the axolotl, also possess excellent regenerating 
skills, they cannot, for example, regenerate their lens (Brockes and Kumar, 2005a).  
 
Even though newts possess unique biological properties and their contributions to our 
understanding in molecular biology is immense, they play a subordinate role in routine laboratory 
work. This is due to the fact that they display a complex and long life cycle. Genetic 
manipulations would last too long to get an investigatable phenotype.  
Furthermore, newts have a huge genome size (Straus, 1971)where repetitive sequences seem to 
occupy most of the genome. Genome sequencing has therefore not been carried out so far, which 
is a major disadvantage. 
 
3.2 Limb regeneration 
 
In general, regeneration can be classified as either epimorphosis or morphallaxis. The latter one is 
characterised by a drastic remodelling of the remaining tissue to regenerate the lost body part. 
9 
This kind of regenerative mode it widely spread throughout the metazoan phylum e.g. in the 
hydra and the planarian worm. 
In contrast to this, epimorphic regeneration proceeds without remodelling of the remaining tissue, 
at least it is restricted to the tissue next to the amputation plane. Establishment of the lost body 
part occurs like an “add-on” process through local formation of a growth zone or blastema at the 
site of amputation. Limb regeneration resembles epimorphic regeneration. 
 
3.2.1 Stages of fore limb regeneration  
 
The process of limb regeneration can be divided into 3 major phases. Each phase is characterized 
by specific stages. A total of 11 stages can be distinguished by morphological and histological 
aspects. The following outline of the stages of fore limb regeneration was obtained from Iten and 
Bryant (1973): 
 
Wound healing is the first stage of the regeneration process (0-5 days after amputation) (Iten and 
Bryant, 1973). Instantly after tissue removal the wound surface is closed by a fibrin clot. After 24 
hours the distal portion of the stump becomes swollen and the wound surface is already covered 
with a thin transparent wound epidermis (Iten and Bryant, 1973). Around 3 days after 
amputation, the wound epidermis is twice as thick (5-7 cells) as the stump epidermis in 
histological sections. Furthermore, the nerves seem to degenerate at their distal ends (Iten and 
Bryant, 1973). 
 
The period of 6-8 days after amputation is an “early dedifferentiation stage” (Iten and Bryant, 
1973). It is characterised by a kind of swollen and translucent wound surface, which appears to 
be blister-like (Iten and Bryant, 1973). Histological alterations involve a further increase in 
thickness of the basement membrane-free apical wound epidermis to 6-11 cells in contrast to 3-4 
cells of the stump epidermis (Iten and Bryant, 1973). First signs of dedifferentiation are visible. 
This is evident through short segments of myotubes containing single nuclei in the vicinity of the 
wound. Additionally, the first blastemal cells can be detected beneath the apical epidermis (Iten 
and Bryant, 1973). 
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The third stage lasts until 11 days after amputation and represents a “late dedifferentiation stage” 
(Iten and Bryant, 1973). Because of a small blister-like swelling, the distal outline of the stump is 
roundish (Iten and Bryant, 1973). In histological sections, dedifferentiation of muscle, bone, and 
degenerating nerves can be observed. The space beneath the apical epidermis is entirely filled 
with loosely arranged blastemal cells (Iten and Bryant, 1973). 
 
Phase I in the forelimb regeneration process comprises these first three stages. This phase takes a 
central role in basic research. In summary, differentiated specialised precursor cells form 
mesenchymal-like cells displaying stem cell properties in a process termed dedifferentiation. 
These cells, referred to as blastemal cells, cumulate beneath the wounded epidermis and are the 
basis for the reconstitution of the lost limb part.  They will redifferentiate into muscle, cartilage, 
bone and connective tissue. 
Therefore, the underlying mechanisms are of great interest for regenerative medicine. Identifying 
the underlying genes/factors, their activation and how they control the establishment of the “stem 
cell” population may render embryonic stem cells dispensable for cells therapy. 
 
The events to follow seem to recapitulate the embryonic development of a limb (Simon and 
Tabin, 1993). Phase II includes blastema accumulation and blastema growth whereas phase III 
comprises differentiation and morphogenesis. 
 
During the “moderate early bud stage” (10-14 days after amputation) the localised swelling 
disappears (Iten and Bryant, 1973). The blastema increases in size and already becomes 
vascularised. Dedifferentiation within the stump tissues is still proceeding (Iten and Bryant, 
1973). 
  
The next stage in limb regeneration is the “early bud stage” (12-17 days after amputation) (Iten 
and Bryant, 1973). The regenerate is still colourless and the limb stump is dome-shaped (Iten and 
Bryant, 1973). Dedifferentiation still continues and expands to more proximal stump tissue (Iten 
and Bryant, 1973).  
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The sixth stage is called “medium bud stage” (14-20 days after amputation) (Iten and Bryant, 
1973). The regenerate appears now cone-shaped and the apex can be either rounded or pointed. 
For the first time, blood flow can be seen within the blastema from without (Iten and Bryant, 
1973).  
The blastema appears as a dense aggregation of cells and dedifferentiation is still in progress (Iten 
and Bryant, 1973). 
 
The “late bud stage” (18-24 days after amputation) (Iten and Bryant, 1973) follows, during which 
the distal portion of the cone apex flattens dorso-ventrally. Afterwards, a bend develops at the 
stump-regenerate-border causing the regenerate to point anteriorly (Iten and Bryant, 1973). 
Histological sections reveal the presence of melanophores within the blastema. For the first time 
chondrogenesis is visible in the proximal part of the regenerate around the distal part of the bone. 
Dedifferentiation is no longer detectable (Iten and Bryant, 1973). 
 
A flattened and paddle-like appearance of the distal tip of the regenerate is the morphological 
characteristics of the “palette stage” (22-28 days after amputation) (Iten and Bryant, 1973). The 
border of the amputation plane is no longer noticeable after the pigmentation of the regenerate 
epidermis has reached a certain level (Iten and Bryant, 1973). Chondrogenesis proceeds to radius 
and ulna, and myogenesis occurs in the proximal part of the regenerate. Blastemal cells are still 
surrounding the newly formed structures resulting from chondrogenesis and myogenesis (Iten 
and Bryant, 1973). 
  
Digit formation occurs during the “early digits stage” (24-33 days after amputation) (Iten and 
Bryant, 1973). The stump is no longer swollen (Iten and Bryant, 1973). The regenerate epidermis 
is reduced in thickness to 4-6 cell layers. However, the distal epidermis is an exception, as it 
appears to project deeply into the interdigital tissue. At this stage, skin glands start to develop in 
the proximal regenerate. By the time of emergence of the first 3 digits, the zeugopodium (radius 
and ulna) is still connected with the autopodium (Iten and Bryant, 1973).  
 
At the “medium digits stage” (30-40 days after amputation) all four digits are present and begin 
to separate from each other (Iten and Bryant, 1973). Cartilage, muscle, and connective tissue 
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dominate within the regenerate. The few residual blastemal cells are mainly in the distal regions 
of the autopodium (Iten and Bryant, 1973).   
 
Limb regeneration is concluded with the “late digits stage” (34 days after amputation) (Iten and 
Bryant, 1973). All digits are separated, elongated, and pointed (Iten and Bryant, 1973). The 
epidermis of the regenerate has the same amount of layers as the stump epidermis (Iten and 
Bryant, 1973). Differentiation is completed and ossification takes place in peripheral regions 
(Iten and Bryant, 1973). 
 
Different levels of amputation, through stylopodium or zygopodium, do not affect the overall 
process of regeneration. From each level of amputation all phases of regeneration are passed at 
approximately the same time. A difference arises only by the onset of the third phase. 
Regenerates from a more proximal level along the proximo-distal axis will increase the rate of 
growth and length compared to regenerates at a more distal level of amputation. Thus, the total 
length of the regenerate is usually reached at approximately the same time independent of the 
level of amputation (Iten and Bryant, 1973). 
 
 
Figure 2. Levels of Fore Limb Regeneration of Notophthalmus 
Viridescens Viridescens 
Each stage is characterised by specific morphological and 
histological alterations (see Section 3.2.1). 
 
(Picture from (Kumar et al., 2007a)) 
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3.3 Blastema 
 
Already 3 days after amputation of the limb, mesenchymal cells start to accumulate beneath the 
wound epidermis. These mesenchymal cells, also referred to as blastema, give rise to the lost 
tissue and rebuild the limb. Blastemal cells only reconstitute the lost part of the limb, depending 
on the actual site/location of amputation. This fact presupposes that blastemal cells inherit 
positional information concerning the proximodistal axis from their ancestors/precursors. 
Blastema graft studies verified this hypothesis. Transplantation of a particular blastema from a 
specific level along the proximodistal axis to the dorsal fin or anterior chamber of the eye 
resulted in corresponding to limb structures at the site of implantation. This feature of the 
blastema is called positional memory and points out its self-organizing properties, which means 
that blastemal cells are independent of any templating or inductive activities of the limb stump 
(Brockes, 1997; Brockes and Kumar, 2005b).  
 
The positional identity of blastemal cells is mediated among other molecules by Prod 1. Prod 1 is 
a small protein anchored at the cell surface establishing a gradient along the proximodistal axis. It 
was identified after studies had revealed that retinoic acid could re-specify distal blastemal cells 
to a more proximal identity (da Silva et al., 2002).  
Investigations to characterise a binding partner of Prod 1 yielded nAG (newt anterior gradient) 
protein as a secreted ligand for Prod 1. Expression of nAG in the regenerating nerve sheath (built 
up by Schwann cells) and wound epidermis depends on an intact nerve in the limb stump. If the 
brachial nerve is cut before amputation, nAG is not expressed anymore and limb regeneration 
arrests in an early step. Ectopic expression of nAG in the distal stump tissue starting 5 days post 
amputation circumvents the presence of an active nerve. Furthermore, nAG enhances 
proliferation of cultured newt blastemal cells when added to the culture medium containing 1% 
serum. Therefore, Kumar et al., (2007b) concluded that nerve dependent expression of nAG 
functions to stimulate proliferation of blastemal cells rather than to have direct effects on their 
positional specification (Kumar et al., 2007b). 
 
The characterisation of nAG was a first explanation why the early steps of regeneration, 
particularly from late phase I to the early stages of phase II, are dependent on nerve supply. More 
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precisely, not the emergence of blastemal cells but their proliferation is directly linked to an 
intact nerve. The outgrowth of the developing limb bud, on the contrary, proceeds in the absence 
of axons. However, when the migration of brachial axons into the embryonic limb bud is 
prevented, regeneration in adult newts is no longer nerve-dependent. Accordingly, innervation of 
the embryonic limb bud appears to establish nerve dependence in adult limb regeneration. 
However, the molecular mechanisms underlying this latter phenomenon are not understood today 
(Ferretti and Brockes, 1991).   
 
3.3.1 Progenitors of the blastemal cells 
 
A central question of epimorphic limb regeneration is the origin of the blastemal cells. 
Histological analysis of early regenerative tissue gave first hints that muscle cells next to the 
amputation plane contribute to the mesenychmal cells that build up the blastema. Syncytial 
muscle cells appeared to have constrictions around their nuclei which would bud off and migrate 
distally to contribute to the mass of progenitor cells which build up the regenerate (Thornton, 
1938).  
The usage of monoclonal antibodies (mab) against regeneration- and tissue specific antigens, 
brought new insights concerning the precursors of blastemal cells. The mab 22/18 specifically 
recognizes a regeneration specific intermediate filament (Kintner and Brockes, 1984). However, 
the intermediate filament is not an exclusive structure in blastemal cells, but rather a 
conformational change in emerging blastemal cells (Ferretti and Brockes, 1990). Next to 22/18, 
Keratin 8 and Keratin 18 mark blastemal cells, although they are also expressed in glands, blood 
vessels and perinerium (perichondrium) in normal limb tissue. Another difference between them 
is that the antigen of mab 22/18 already appears 36-48 hours after amputation whereas the 
expression of Keratin 8 and Keratin 18 only starts 3 days after amputation (Ferretti and Brockes, 
1991). 
The combination of 22/18 with different tissue specific markers brought up a number of potential 
sources of progenitors. Markers of Schwann cells were coexpressed with antigen 22/18 in the 
most proximal blastema cells. A component of the sarcoplasmic reticulum could be detected in a 
few 22/18 positive cells and markers of fibroblasts were co-expressed in the majority of 
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blastemal cells. In contrast, neither epidermal nor wound epidermis-specific markers were co-
expressed in 22/18 positive cells (Ferretti and Brockes, 1991). 
The origin of blastemal cells could be connected with dedifferentiation. This theory implies that 
mature, differentiated tissues undergo a transition to an earlier developmental stage. Syncytial 
muscle gives rise to mononucleated cells while chondrocytes leave the cartilage matrix and 
Schwann cells exit the myelin sheath to build up the blastemal stem cell mass.  
Another origin of blastemal cells could be tissue specific stem cells. Such tissue restricted stem 
cells have to go through a dedifferentiation process as well, to be able to give rise to cells of 
different lineages.   
Recently, Morrison et al. (2006) could isolate a Pax7 positive cell fraction from in vitro cultured 
newt single myofibers. Myofibers injected with tracing dye yielded proliferating offspring 
without the injected label. This observation led to the discovery of newt satellite cells inside the 
basement membrane of muscle cells. Furthermore, intramuscular injection of BrdU-labeled newt 
satellite cells prior to amputation verified that these cells contribute to the blastema. 
Subsequently, the labeled cells differentiated into cartilage and were also detected in the wound 
epidermis. Differentiation studies in vitro showed the potential of this cell type to differentiate 
into cartilage, adipocytes and muscle (Morrison et al., 2006). 
 
Furthermore, it is important to consider the quantity of cells contributed to the blastema by the 
different tissues. Echeverri at al. (2001) found out that a 4 day old axolotl tail blastema consists 
of 907 blastemal cells. 43% of those are derived from the dermis and 16.5% arise from 
dedifferentiation of muscle next to the amputation site. The remaining 40.5% are derived from 
other sources within the stump tissue (Echeverri et al., 2001). 
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3.4 Dedifferentiation of muscle cells 
 
3.4.1 Dedifferentiation 
 
The transition of the multinucleated muscle cell to mononucleated cell progeny requires changes 
on the molecular as well as the cellular level (see Fig. 3) (Duckmanton et al., 2005). 
Dedifferentiation involves transcriptional repressors of genes, which constitute the differentiated 
state. At the same time other genes are activated that establish the new properties of blastemal 
cells. 
 
 
Figure 3. Different Aspects of Muscle Dedifferentiation 
 
This diagram lists steps, which have to be fulfilled to yield 
mononucleated progeny form syncytial muscle cells.  
 
(Figure from Duckmanton et al., 2005) 
 
 
 
Msx-1, a homeobox protein, is suggested to play a central role in the initiation of the 
dedifferentiation process. Explant cultures of single viable axolotl myofibers displayed a diverse 
behaviour. Myofibers responding to dissociation were characterised by migration of nuclei within 
the syncytium and formation of lobulated structures in the middle or at the end of the cell. 10% of 
the total population of myofibers formed these lobules, containing a single nucleus, which 
budded off and gave rise to mononucleated cells. Besides these mononucleated cells which could 
be labeled with tritiated thymidine (a marker for DNA synthesis), 40%-70% of the total 
population of myofibers gave rise to progeny containing 2 to 3 nuclei. These multinucleated 
fragments could not be labelled with tritiated thymidine (Kumar et al., 2004). 
Fragmenting myofibers responding to dissociation were termed “activated”. Activation was 
associated with Msx-1 expression whereas non-responding, inactive myofibers did not express 
Msx-1 (Kumar et al., 2004).  
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At this point, a brief overview of cellularisation/fragmentation of muscle cells is given to 
illustrate the possibilities of the origin of mononucleated progeny (see Fig. 4). 4 different possible 
strategies are known, either comprising an active cell cycle progression or quiescent nuclei 
(Velloso et al., 2000). Concerning the strategies involving an active cell cycle there are two 
possibilities. 
First, budding could be an effect of mitosis and subsequent cytokinesis.  
Second, entry into G1 phase or S-phase could be the inducer to force these “active” nuclei to exit 
the differentiated environment. 
On the other hand, budding has not to be obligatorily linked to active nuclei. It is also possible 
that under the influence of a certain environment, after tissue injury or in a blastema, nuclei are 
initially forced to form mononucleated progeny. Afterwards, the derived progeny start to 
proliferate. 
The fourth exit strategy, a variant of the latter one, is the escape of nuclei from a cluster of 
myotube nuclei. This hypothesis corresponds with observations of osteoclast-like multinucleated 
giant cells (Velloso et al., 2000).  
 
 
Figure 4. Different Possibilities How Mononucleated Progeny 
could Originate from Myotubes 
 
Black nuclei re-entered the cell cycle whereas red nuclei are 
quiescent. 
 
(Figure from (Velloso et al., 2000)) 
 
 
How cell cycle re-entry and cellularisation/fragmentation are connected to each other is not well 
understood. As described later, cell cycle re-entry occurs without cellularisaton/fragmentation 
(Tanaka et al., 1997). On the other hand, cultured A1 (a newt myogenic cell line) myotubes, 
which were blocked for cell cycle re-entry, produce mononucleated offspring when injected into 
the blastema (Velloso et al., 2000).  
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Previous studies on mammalian myotubes revealed that terminal differentiation could be 
overcome by genetic manipulations. Mouse myotubes lacking both copies of the retinoblastoma 
gene responded to growth factors in the medium by entering the cell cycle (Schneider et al., 
1994) .  
Viral oncogenes can cause cell cycle re-entry as well. Ectopic expression of SV-40 large T 
antigen or adenovirus E1A protein induced the nuclei of mammalian myotubes to re-enter the cell 
cycle. Adenovirus E1A protein expression reduced the levels of muscle-specific proteins, as well, 
whereas SV-40 large T antigen transfection yielded smaller myotubes or non-proliferating 
mononucleated cells (Endo and Nadal-Ginard, 1998; Iujvidin et al., 1990). 
  
3.4.2 Cell cycle re-entry by serum stimulation 
 
Cultured A1 newt myotubes are able to re-enter the cell cycle. This feature depends on the 
phosphorylation of the retinoblastoma (Rb) protein. The Rb protein is a regulator of the G1/ S 
restriction point of the cell cycle. It functions as an upstream regulator of E2F transcription 
factors, which are required to enter S-phase. Phosphorylated Rb protein has a reduced affinity to 
E2F, so that free E2F is able to initiate S-phase. In mammalian cells, this pathway seems to be 
exclusive for proliferation sensitive and thus undifferentiated cells. However, newt myotubes 
retain the ability to respond to elevated levels of serum (from various mammalian sources) by 
phosphorylation of the Rb protein and thus entering the S-phase. However, cell cycle re-entry 
was inhibited, if the myotubes were in contact with surrounding mononucleated cells (contact 
inhibition). The overexpression of a mutant Rb protein lacking the phosphorylation sites 
prevented newt myotubes to re-enter S-phase. Furthermore, if myotubes were responding to 
elevated levels of serum in the medium, all their nuclei incorporated BrdU. Thus, cell cycle 
progression occurs but arrests in G2 (Tanaka et al., 1997). 
 
Cell cycle re-entry depends on activation of a serum component by thrombin or plasmin. After 
the addition of thrombin/plasmin (thrombin is more potent than plasmin) to sub-threshold amount 
of serum-containing medium, S-phase re-entry could be observed. Sub-threshold amount of 
serum corresponds to 1.5% serum (Tanaka et al., 1999).  
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This property is not exclusive for newt myotubes. In newt/mouse hybrid cells, mouse nuclei are 
responsive to serum as well. In this situation the postmitotic arrest of the murine nuclei is 
overcome by the same pathway that is activated in the newt cytoplasm after serum stimulation 
(Velloso et al., 2001).   
 
3.4.3 Newt regeneration extract causes dedifferentiation of cultured myotubes 
 
Protein extracts from early blastemal tissue, including blastemal cells and wound epidermis cells, 
were used to assay their effect on cultured newt and murine myotubes. Purified myotubes from 
both species cultured in low serum medium were exposed to the protein extract and responded in 
a comparable fashion (McGann et al., 2001). 
25% of newt myotubes re-entered the cell cycle after incubation in regeneration extract and all of 
the nuclei incorporated BrdU. Cellular cleavage of newt myotubes became apparent between 3-5 
days after exposure to the extract. 16% of the cells cleaved to form smaller myotubes or even 
mononucleated cells (McGann et al., 2001). 
64% of responding mouse myotubes re-entered the cell cycle of which only 19% exhibited DNA-
synthesis. Cleavage of the cells was observed as well although at the lower level of 11%. 
Approximately half of the cells resulting from cleavage also started proliferating. Furthermore, 
the levels of MyoD and myogenin were reduced in the nucleus while the level of troponin T was 
decreased in the cytoplasm of treated mouse myotubes. MyoD, myogenin and troponin T are 
markers for terminally differentiated muscle (McGann et al., 2001). 
 
3.4.4 Ectopic expression of msx-1 induces dedifferentiation in murine muscle cells 
 
As described in Section 3.4.1, Msx-1 seems to be a marker of dedifferentiation competent 
myotubes (Kumar et al., 2004) and a key regulator in the early phase of dedifferentiation. Ectopic 
expression of an inducible msx-1 gene combined with growth medium (high serum) stimulation 
forces cultured mouse myotubes to undergo dedifferentiation (Odelberg et al., 2000). The 
dedifferentiation process is initiated by down-regulation of factors essential for muscle 
differentiation. On the first day after induction of Msx1, the muscle differentiation marker MRF4, 
myogenin and p21 levels were already reduced. MyoD reduction set in on the second day. 
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Furthermore, on the second day after Msx1 induction the first signs of cleavage could be 
detected, including stretching of the cells and subsequent cleavage at the end of the myotubes as 
well as the emergence of progenies from the core of the myotubes. 8.8% of investigated 
myotubes underwent cleavage and gave rise to multinucleated fragments or even mononucleated 
offspring. Subsequently, a fraction of the mononucleated offspring started to proliferate. Clonal 
populations of dedifferentiated cells were further tested to transdifferentiate into different cell 
lineages. Indeed, it was shown that these clonal populations were competent to redifferentiate 
into cell types expressing markers of chondrogenesis, adipogenesis, osteogenesis and myogenesis 
(Odelberg et al., 2000).  
 
3.4.5 Dedifferentiation induced by small molecules 
 
Myoseverin, a trisubstituted purine, was identified by screening a purine library, to have a direct 
effect on differentiated mouse muscle cells (Rosania et al., 2000). After exposure of myotubes to 
myoseverin the cells developed cytoplasmatic constrictions between the nuclei. The shape of the 
myotubes resembled a beads-on-a-string motive. Myoseverin caused a disintegration of the 
microtubule structure, forming short fragmented microtubules between the nuclei instead of 
parallel bundles aligned with the long axis of the myotube. Additionally, removal of myoseverin 
and subsequent culture in proliferation medium yielded BrdU positive cells which points to cell 
cycle progression (Rosania et al., 2000). 
Microarray analysis revealed that incubation of myotubes in myoseverin leads to an altered 
transcriptional profile compared to untreated control cells. Interestingly, myoseverin did not 
significantly affect genes involved in cell cycle and muscle specification. Instead, around one half 
of the transcripts affected by myoseverin are involved in wound healing and tissue repair, 
comprising genes involved in extracellular matrix remodelling, inflammation, coagulation, signal 
transduction and cell communication (Rosania et al., 2000). 
 
A triazine compound, which shows structural similarity to myoseverin, also forces mammalian 
myotubes to cellularise (Duckmanton et al., 2005). Cellularisation was caused again by 
disruption of the microtubule cytoskeleton. Neither BrdU incorporation nor proliferating progeny 
could be detected by time-lapse microscopy. Centrioles, which are critical structures for cell 
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cycle progression are progressively lost during differentiation. In mononucleated cells derived 
from incubation with the triazine compound, a re-appearance of centrioles in the ratio 2:1 with 
the nucleus could not be detected. This absence of centrioles in the progeny could possibly be the 
cause of the absent mitotic activity. In contrast to the experiments performed with myoseverin, as 
described above, experiments with the triazine compount were carried out on pmi28 cells. The 
pmi28 cell line, also a mouse myogenic cell line, is more stable in culture and results in a higher 
proportion of long, narrow and unbranched myotubes. These characteristics seem to be 
responsible for the higher responsiveness of the pmi28 myotubes to cellularisation for the triazine 
compound and for myoseverin. Unfortunately, results obtained from incubation with myoseverin 
concerning cell cycle re-entry could not be repeated on pmi28 cells (Duckmanton et al., 2005). 
 
3.4.6 Implantation and in vivo studies of muscle dedifferentiation 
 
Dedifferentiation could be observed by microinjection of cultured newt myotubes with 
rhodamine-dextran and subsequent transplantation under the wound epidermis of early 
regenerating limbs (Lo et al., 1993). The tracing dyer could not be transferred between cells. 
Therefore, it could be excluded that adjacent blastemal cells become stained unintendedly. By 
harvesting blastemas at different time points after transplantation an increase of labeled 
mononucleated cells was observed. Thus, it was concluded that the initially labeled myotubes 
cellularised and further proliferated. After 4-6 weeks the dye disappeared through dilution by 
proliferation. Nevertheless, the dye was also present in a few newly differentiated chondrocytes 
(Lo et al., 1993). 
The above mentioned result was verified by using a different staining strategy. Insertion of a 
genetic marker (human placental alkaline phosphatase) into the A1 cell genome the (minor) 
possibility was excluded that labeled mononucleated cells originated from cytoplasmic transfer of 
the rhodamine-dextran linage tracer (Kumar et al., 2000). Transplantation of these stained 
myotubes into the early regenerating tissue gave rise to labeled mononucleated offspring. 
Furthermore, as an expansion of the above-mentioned experiment, BrdU injection was performed 
9 days after transplantation. Analysis after 24 hours revealed that BrdU incorporation was not 
restricted to the implanted labeled muscle progenitors and blastemal cells. Instead, nuclei in 
muscle at the distal stump tissue were BrdU labeled as well (Kumar et al., 2000). The observation 
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of cultured newt muscle cells re-entering the cell cycle after transplantation was consistent with 
the results described in Section 3.4.2 where cultured A1 myotubes exposed to elevated levels of 
serum displayed BrdU incorporation.   
To learn more about the relationship of cell cycle re-entry and cellularisation (Velloso et al., 
2000) studied transplanted myotubes inhibited in cell cycle progression. Cell cycle re-entry was 
either blocked by X-irradiation or by ectopic expression of p16, an inhibitor of the CDKs 4 and 6 
which are essential for G1/S transition. Although, progression through the cell cycle was blocked 
mononucleated cell offspring was detected within the regenerate (Velloso et al., 2000). 
 
By using the Ambystoma mexicanum (Axolotl) larva which has a thin and translucent skin it is 
possible to observe single traced cells by Nomarski imaging. (Echeverri et al., 2001) revealed 
new insight into muscle dedifferentiation by applying this method. After fluorescence labelling of 
a myofiber in situ it was possible to follow this individual syncytial cell. Results verified previous 
muscle dedifferentiation data exclusively gained on static observations. An interesting finding of 
this study was that dedifferentiation was only observed if a small cytoplasmic portion was 
clipped from the end of the muscle cell accompanied by severe tissue injury at the site of surgery. 
The morphology of the resulting mononucleated cells resembled those of blastemal cells 
(Echeverri et al., 2001). 
 
3.6 Chromatin 
 
Deoxyribonucleic acid (DNA) is the primary information storage system of life. Besides DNA, 
there is another system which determines how the primary DNA-information has to be used 
during different developmental stages in different cells. This second, superordinate system over 
the DNA, is referred to as the epigenetic system of the chromatin.  This epigenetic system 
comprises DNA methylation and histone proteins with various posttranslational modifications 
(Thiagalingam et al., 2003). A nucleosome, the smallest unit of chromatin, is composed of 4 
different histone proteins (H2A, H2B, H3 and H4) which build up a globular histone octamer 
wrapped around by roughly two turns of DNA (see Fig. 5). The carboxy terminal parts, which 
build up a globular structure, are located within the nucleosome whereas the amino terminal tails 
of the histones are flexible, charged and accessible and thus are subject to posttranscriptional 
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modifications. Specific amino acid residues of these amino terminal tails can be modified by 
phosphorylation, acetylation, methylation or ubiquitination (Jenuwein and Allis, 2001). 
 
Figure 5. Schematic Illustration of a Nucleosome 
 
The amino terminal tails of the histone proteins (H2A, H2B, H3 
and H4) are flexible and protrude from the nucleosome (not 
visible in this scheme). Therefore, they are able to interact with 
the DNA and are subject to various posttranslational 
modifications. 
 
(Figure from (Monneret, 2005)) 
 
 
The importance of epigenetic information storage becomes obvious by the comparison of 
monozygotic twins. Although these individuals possess identical genetic sequences differences in 
anthropomorphic characteristics and sensitivity to diseases can be observed. These variations 
often arise in older twins who have led separate lives or had divergent natural health-medical 
histories. This becomes evident in differing DNA methylation and histone H3 and H4 acetylation 
patterns (Fraga et al., 2005). 
Whether a gene is transcribed or not depends, from an epigenetic point of view, on the 
arrangement of chromatin. Chromatin, at the level of transcription, can be at least divided in 
either euchromatin or heterochromatin (Jenuwein and Allis, 2001). Heterochromatic sections are 
dense structures which are cytologically visible as heterochromatic foci during interphase. Genes 
located within euchromatic DNA-sections are transcribed whereas genes inside heterochromatic 
sections remain inaccessible for transcription factors. This location dependent variation of 
expression is known as position-effect variegation (PEV) (Jenuwein and Allis, 2001). To alter the 
status of a gene (on-off state) two groups of proteins exist which have antagonizing effects on 
chromatin. Factors which positively influence transcription and/or degrade or destabilize 
heterochromatic marks belong to the class of E(var) proteins (enhancer variegation) whereas 
factors suppressing transcription belong to the Su(var) (suppressor variegation) family. E(var) 
protein family members are e. g. histone acetyltransferases (HAT) and factors which increase 
nucleosomal mobility (e. g. SWI/SNF).  Antagonizing factors belonging to the Su(var) group 
24 
include proteins such as histone deacetylases (HDACs), protein phosphatases (PPtases) and 
depending on of their substrate histone methyltransferases (HMTases) (Jenuwein and Allis, 2001; 
Rea et al., 2000). 
Furthermore, the important developmental regulators of the Polycomb (Pc-G) and trithorax (trx-
G) groups belong to the PEV.  Pc-G belongs to the Su(var) factors whereas trx-G functions to 
establish euchromation marks like the members of the E(var) group (Jenuwein and Allis, 2001).    
Though performing different functions on the chromatin scaffold, members of both groups share 
highly conserved protein domains. These are the bromo-, chromo- and SET domains, which are 
conserved from yeast to man (Jenuwein and Allis, 2001; Rea et al., 2000). The bromo domain 
functions in the recognition of acetylated histone residues, the chromo domain mediated the 
recognition of methylated histone residues whereas the SET domain has histone 
methyltransferase (HMTase) activity. The bromo- and chromodomains are the docking domains 
of histone modifying enzymes. Specificity to a specific location and modified amino acid on the 
histone tail are the results of recognition of modification marks in a certain context. There are 
proteins which contain up to six bromodomains. Most likely, this further increases substrate 
specifity by binding only to groups of acetylated marks that are spaced in a correct manner. 
Furthermore, this reflects the interdependence of various modification on the same or 
neighbouring histone tails. These findings seem correlate with the predicted “histone code” 
hypothesis, that combinations of histone modification marks serve as binding sites for chromatin 
remodelling complexes (Jenuwein and Allis, 2001). 
On the other hand, already established marks have influence on the addition of further marks. For 
example, histone H3 lysine 9 (H3K9) dimethylation alleviates phosphorylation of histone H3 
serine 10 (H3S10) whereas phosphorylated H3S10 and acetylated H3K9 block H3K9 
methylation. In contrast, acetylation of histone H3 lysine 14 (H3K14) and H3K9 enhances 
phosphorylation of H3S10 over the total rate of unmodified substrate in vitro (Rea et al., 2000). 
This illustrates that an already established posttranslational mark influences further deposition of 
marks on the same histone overhang. This can be either in a synergistic or antagonizing way.  
Enzymes exist for each of the different posttranslational histone tail modifications identified so 
far, which can remove the added mark. Therefore, the whole system seems to be rather plastic. 
However, surprisingly, epigenetic marks can even be inherited which is now an established 
observation (Jenuwein and Allis, 2001).   
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In general, acetylation and methylation at specific loci can be mapped to either activation or 
repression of gene expression. Acetylation of histone tail residues is generally linked with 
activation (Strahl and Allis, 2000) whereas methylation can either be activating or repressing, 
depending on the position of the modification. On the whole, it can be said that single 
modifications do not seem to be responsible whether transcription of a gene is turned on or off 
(Strahl and Allis, 2000). Instead, various modifications on histone tails at certain loci are 
interdependent in triggering or repressing transcription. This combination of different 
modifications is believed to reflect a “histone code” (Jenuwein and Allis, 2001). 
Methylation can either take place at arginine, which is in general an active mark, or at lysine 
residues, which can be active or repressive marks. Activating methyl lysine marks are H3 lysine 
4, 36 and 79 methylation, respectively, whereas methylation of H3 lysine 9, 27 and H4 lysine 20, 
respectively, marks repression. Lysine can either be mono-, di-, or trimethylated (Klose et al., 
2006), presumably reflecting the strength of activation or repression.  
 
3.6.1 Histone H3 lysine 9 (H3K9) methylation 
 
Methylation of H3K9 marks transcriptionally silent chromation regions (Nakayama et al., 2001). 
Enzymes attaching this mark belong to the originally identified PEV modifier family Su(var)3-9 
of Drosophila. These enzymes are conserved from Schizosaccharomyces pombe (Clr4) to men 
(SUV39H1) (Rea et al., 2000). 
They share the highly conserved SET domain and chromodomain. The SET domain is bordered 
by cysteine-rich regions. These regions constitute the catalytic centre, which is sufficient to 
specifically attach the methyl group to the lysine on position 9 at the amino terminal end of 
histone H3 in vitro (Nakayama et al., 2001; Rea et al., 2000). However, in vivo experiments 
pointed out that the chromodomain is further required to effectively establish the heterochromatic 
mark (Nakayama et al., 2001). 
Upon formation of this methyl mark, heterochromatin protein 1 (HP1) binds via its 
chromodomain and stabilizes the mark by establishing constitutive heterochromatin, e.g. 
pericentric regions (Lachner et al., 2001; Nakayama et al., 2001). 
Besides its involvement in the origin of constitutive heterochromatin, methylation of lysine 9 on 
histone H3 is also required in the regulation of facultative heterochromatin, e.g. developmental 
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genes. However, establishment of facultative heterochromatin seems to be catalysed in a 
Suv39h1 (mouse homologous to SUV39H1 of humans) independent manner and further proceeds 
without HP1 binding (Peters et al., 2002). 
 
Enzymes removing this repressive H3K9 mark, either use flavin, such as lysine-specific 
demethylase 1 (LSD1), or iron and α-ketoglutarate as cofactors within their conserved JumonjiC 
(JmjC)-domain such as Jmjd1a and Jmjd2c. The latter ones are members of the JmjC-domain-
containing histone demethylases (JHDMs) which can reverse all three methylation statuses of 
lysine residues (Klose et al., 2006). 
LSD1 is capable of demethylating mono- and dimethylated lysine residues (Klose et al., 2006). 
Substrate specificity is achieved in a ligand dependent manner. Therefore, LSD1 can either 
function as a transcriptional activator (Metzger et al., 2005) or transcriptional repressor (Shi et 
al., 2004).   
Jmjd1a and Jmjd2c are positively regulated by Oct4 and are essential to maintain the self-renewal 
and pluripotent (“stemness”) state of embryonic stem (ES) cells. Jmjd1a specifically 
demethylates H3K9 dimethylation at the Tcl1 promoter whereas Jmjd2c is required for the active 
transcription of Nanog by demethylating the H3K9 trimethylated Nanog promotor (Loh et al., 
2007).  
 
3.6.2 Trichostation A (TSA) 
 
Histone NH2-terminal acetylation is catalyzed by histone acetyltransferases (HATs), which attach 
acetyl-groups, and histone deacetylases (HDACs), which remove this mark. Histone acetylation 
takes place at definite lysine residues which can overlap with methylation, e.g. H3K9 (see 
above). Hyperacetylation at a certain locus is commonly associated with active transcription. On 
the other hand, transcriptionally silent heterochromatin is usually marked by hypoacetylation. 
The degree of acetylation is regulated via shifts in the equilibrium of acetylation and 
deacetylation. Thus, HDAC inhibition results primarily in an increase of histone acetylation 
(Monneret, 2005; Yoshida et al., 1990). 
There are 3 different groups of HDACs. The classification is based on similarity to the forms 
initially identified in yeast.  Class 1 HDACs share homology to the Rpd3 protein in yeast and 
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comprises HADC 1, 2, 3 and 8. They are located within the nucleus. Class 2 HDACs (HDAC 4, 
5, 6, 7, 9 and 10) are similar to the yeast Hda1 protein. They are located in the cytoplasm and 
nucleus. The third class of HDACs resembles the Sir2 protein from yeast which are NAD-
dependent enzymes and thus structurally different from class 1 and class 2 (Thiagalingam et al., 
2003). 
 
TSA (see Fig. 6) was isolated from Streptomyces hygroscopicus and originally identified as an 
antifungal antibiotic. It is a potent inhibitor of class 1 and class 2 HDACs in a noncompetitive 
way even at nanomolar concentrations (Kyrylenko et al., 2003; Yoshida et al., 1990). It interacts 
with the active centre, which is conserved in class 1 and class 2 HDACs (Finnin et al., 1999). 
The consequences of HDAC inhibition are heterogeneous and, as far as they are known, range 
from cell cycle arrest and differentiation (Yoshida et al., 1995), activation of host immune 
response and inhibition of tumor angiogenesis (Monneret, 2005), to caspase 3 activation 
promoting apoptosis (Salminen et al., 1998). Therefore, one possible promising application of 
HDAC inhibitors would be cancer therapy (Johnstone, 2002).  
 
 
Figure 6. Molecular Structure of TSA 
 
(Figure from www. Sigmaaldrich.com) 
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3.7 Specific aim of the study 
 
The specific aims of this study were twofold: 
 
First, to examine chromatin modifications on histological sections of regenerating tissue of the 
newt aiming at the identification of differences in histone methylation patterns between normal 
and regenerating tissues. 
Tissue from phase I of the limb regeneration process (see Section 3.2.1) was used because we 
wanted to investigate changes in chromatin-modifications in blastema progenitors. In particular, 
the focus was on the process of dedifferentiation of differentiated tissue. 
Based on differences in chromatin methylation patterns reactivated cells should be distinguished 
from limb tissue cells.  Methylation at specific residues at the NH2-terminal domain of histone H3 
characterise transcriptionally silenced domains (see above). An indication of dedifferentiating 
cells should be gained by comparing tissue sections of different time points of the initial stages of 
limb regeneration. As it is hypothesised that the loss of methylation in a given cell/tissue is a sign 
of re-activation and further dedifferentiation, special attention was paid to the loss of methylation 
marks.    
 
Second, to assess how changes in chromatin modifications may influence skeletal muscle cell 
plasticity. In particular, the effect of histone deacetylase (HDAC) inhibitor Trichostatin A (TSA) 
on the plasticity of newt myotubes (A1) and murine myotubes (C2C12) was examined. 
Experiments were performed to gain insight to the molecular mechanisms underlying 
dedifferentiation. 
However, the triggers for the dedifferentiation process are known (Echeverri et al., 2001; 
McGann et al., 2001; Odelberg et al., 2000) knowledge of the underlying mechanism is almost 
absent. 
Therefore, we tried to define the role of histone deacetylases during the dedifferentiation process. 
Histone deacetylases are regulatory enzymes whose substrates are located in the nucleus and 
cytoplasm depending on the HDAC.  
Previous experiments in our laboratory already indicated that serum treatment induced cell cycle 
re-entry of cultured newt myotubes which is accompanied by histone H4 lysine 12 acetylation. 
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This result triggered our investigation of the direct increase of elevated acetylation levels in 
detail.  
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4. Results 
 
Preliminary analyses were carried out to uncover possible changes in the state of chromatin of 
normal and early regenerative tissue, respectively. 
Furthermore, to test whether histone deacetylation is involved in the process of myogenic 
dedifferentiation and to learn more about the plasticity of the differentiated state, the effects of 
TSA on differentiated myotubes were analysed. Of particular interest was the ability of TSA to 
induce the fragmentation of multinucleate myotubes to progeny with a reduced number of nuclei 
or with only one nucleus.  
 
4.1 Differences in histone modifications between normal limb tissue and 
regenerating stump tissue in situ 
 
Antibodies against histone H3 lysine 9 (H3K9) methylation patterns were used to examine 
chromatin alterations during the initial steps of regeneration. 
For this purpose, tissue sections of normal limb and regenerating stump tissue of day 3 and 10 
post amputation (p.a.) (see Material and Methods) were stained with antibodies against histone 
H3K9 di-methylation, histone H3K9 tri-methylation (see Introduction) and DAPI.   
Afterwards, the cells were screened for differences in the methylation state in relation to their 
anatomical location. Antibody staining in combination with DAPI staining showed that the 
antibodies specifically stained the nucleus, as had been expected. This was important, as there 
have been no reports of these antibodies working in newts, so far. 
 
In addition to the specific binding in the nucleus, the antibody against tri-methylated histone 
H3K9 produced a strong background signal. This phenomenon was observed on normal limb 
tissue sections and sections taken three and ten days after amputation, mostly in muscle cells and 
extracellular structures (see Fig. 7). Generally, signal intensity of this antibody was weaker than 
the one seen with the antibody against histone H3K9 di-methylation. 
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In normal limb tissue sections both antibodies bound uniformly throughout the whole tissue 
section. Fig. 7 shows that all nuclei stained with DAPI were also positive for histone H3K9 di-
methylation and tri-methylation, respectively. This is consistent with the expected result under 
physiological condition without trauma. 
Furthermore, throughout the sections analysed, in many nuclei a zone could be observed where 
the staining signal was more intense. This effect was not observed in all nuclei, presumably due 
to how the cells were sliced (see Fig. 7). 
Moreover, the intensive nuclear staining zone was rare with the antibody against tri-methylated 
histone H3K9 as compared to the antibody against di-methylated histone H3K9.  
 
                     DAPI                                 Histone Methylation                                  Merged 
       
 
       
 
       
 
Figure 7. Uniform Histone H3K9 Methylation in Non Regenerating Newt Limb 
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Upper row: Section from normal newt limb tissue stained against di-methlyation of histone H3K9. As can be seen, 
there is no obvious difference between single cells throughout the tissue. Except, in the upper left corner of the 
images where a portion of the epidermal layer can be seen. The epidermis is generally very intensively stained. 
Middle row: Zones within the nuclei with more intensive staining compared to the surrounding chromatin (indicated 
by arrows) 
Bottom row: The unspecific binding of the antibody against histone H3K9 tri-methylation. As can be assumed by 
staining pattern the structures are mainly to muscle tissue and extracellular matrix. 
 
Analysis of the di-methylation state of tissue sections 3 and 10 days p.a. revealed a change in the 
signal intensity and staining pattern of this antibody.  
3 days p.a., the staining intensity was comparable to normal limb sections. An exception was a 
zone beneath the wound epidermis, in the very early regenerative tissue, where DAPI and histone 
H3K9 di-methylation signals were practically absent. 
However, in tissue sections 10 days p.a. a visible change of staining pattern occurred. 
Importantly, signal intensity in the blastemal cells was noticeably reduced (see Fig. 8). Moreover, 
a very dominant region of the dermis was detected directly beneath the epidermal layer at the 
blastema-tissue boundary. However, it was not possible to further characterize these cells at that 
time. Furthermore, the cells in the centre of the regenerate beneath the wound epidermis were 
very weakly stained.  
Tissue proximal to the amputation site appeared unchanged compared to normal tissue.  
 
In contrast to the staining performed against histone H3K9 di-methylation, staining intensity 
against histone H3K9 tri-methylation changed already on day 3 p.a.. In this case, staining 
intensity on day 3 p.a. against histone H3K9 tri-methylated was already comparable to that 
observed in tissue sections 10 days p.a. stained for histone H3K9 di-methylation. Again, the 
region beneath the epidermal layer was the most dominant in terms of a reduction of signal 
intensity besides the blastemal cells. Only very faint staining could be observed in this zone (see 
Table 1). 
After day 3 p.a. staining intensity against histone H3 lysine 9 tri-methylation remained constant 
up to day 10 p.a.. 
As before, proximal to the amputation plane staining appeared similarly as has been detected in 
normal limb tissue sections.  
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                     DAPI                               Histone Di-methylation                              Merged 
       
 
       
 
Figure 8. Change in Histone H3K9 Di-Methylation 10 Days Post Amputation 
 
Upper row: Blastemal cells. Compared to normal limb tissue an obvious reduction of histone H3K9 di-methylation 
can be detected. 
Bottom row: Image of the blastema-tissue boundary. Epidermal cells (on the right) seem to be unaffected though 
cells beneath the epidermal layer are slightly reduced in histone H3K9 di-methylation compared to normal limb 
tissue sections. 
 
In the epidermal layer no change could be observed in the staining patterns of either of the two 
antibodies at all three time points. 
 
 Epidermis 
H3K9dM / H3K9tM 
Dermis  
(at amputation site) 
H3K9dM / H3K9tM 
Blastema 
H3K9dM / H3K9tM 
Normal limb tissue 3 / 3 3 / 2 N / A 
3 days post-amputation tissue 3 / 3          2.5 / 1 0.5 / 0.5 
10 days post-amputation tissue 3 / 3   1 / 0.5 0.5 / 0.5 
 
Table 1: Categorization of Staining Intensities at Distinct Regions 
 
0 to 3 represents the staining intensities observed where 0 indicate no staining and 3 the strongest. 
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4.2 Trichostatin A (TSA) triggers murine myotubes to dedifferentiate 
 
To examine the effect of TSA on dedifferentiation, C2C12 cells were grown to confluence and 
induced to differentiate into myotubes. Myotubes are terminally differentiated by definition. This 
means that they are multinucleated and express markers of terminal differentiation, for example 
myosin heavy chain (MHC) and muscle creatine kinase (MCK). Furthermore, they are also 
refractory to growth factor stimulation. 
96 hours after induction to differentiate, myotubes were picked (see Materials and Methods) in 
order to obtain samples without mononucleated cells. Thus, preexisting contamination with 
mononucleated cells was reduced to a minimum, which was essential as the mononucleated 
offspring generated by TSA-treatment were the subjects of interest.  
 
In order to determine the conditions under which most myotubes formed progeny with fewer 
nuclei or with a single nucleus, different incubation times with variable concentrations of TSA 
were tested.  
At first, a concentration of 50 ng/ml TSA in conditioned differentiation medium (see Section 
6.1.6) was applied for 8 hours. Afterwards, the TSA action was terminated by changing to fresh 
conditioned differentiation medium. The wells were fixed in intervals of eight hours, such that 
the first well was fixed immediately after changing to fresh medium, and the last well 32 hours 
after the termination of TSA treatment. 
 
The same procedure was repeated with constant TSA concentration but different incubation 
times. TSA was added for 16, 24, and 32 hours, respectively. Rinsing of the TSA containing 
medium and subsequent incubation in conditioned differentiation medium for 0, 8, 16, 24 and 32 
hours before fixations were performed as described above (see Fig. 9).  
 
These treatments did not yield significant numbers of myotube fragmentation. Most likely the 
initial TSA concentration was too high, since the number of myotubes decreased rapidly due to 
cell death the longer the treatment lasted. Furthermore, a significant decrease in MHC signal 
intensity was observed with increasing incubations. 
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Figure 9. Schematic Illustration of Experimental Procedure 
 
Experimental settings, as indicated in the scheme and described in Material and Methods, were always the same. The 
initial number of myotubes before the experiments was around 50 per well. Time points in the last row indicate the 
period of incubation in conditioned differentiation medium between TSA treatment and fixation. 
Myotubes are indicated by elongated cells containing 4 nuclei. Mononucleated cells have triangular shape in this 
scheme. Fragmentation offspring are indicated by longish cells containing two nuclei. Red indicates MHC-positive 
cells, white indicates MHC-negative cells. 
(A) Control wells were not incubated with TSA but were otherwise treated similarly. Residing contamination with 
mononucleated MHC-negative cells is indicated in the scheme while the background of mononucleated MHC-
positive cells was omitted. 
(B) Expected result: Cellularisation is induced by TSA treatment. As a result, mononucleated MHC-positive cells 
besides syncytial myotubes can be observed. After longer periods of time average cell number is reduced by cell 
death. 
(C) Actual result: Myotube fragmentation into progeny containing less nuclei was induced by TSA. Best results were 
obtained by fixation 16 hours after TSA treatment. Again, a considerable number of cells died after longer 
periods of time. Mononucleated MHC-positive cells above background level could not be observed. 
 
 
Therefore, TSA concentration was decreased in subsequent experiments. Fixation was performed 
immediately after TSA incubation. As the presence of MHC served as a marker to identify 
mononucleate cells derived from multinucleated myotubes, it was very important to monitor 
MHC levels throughout the experiment. 
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Results were analysed after fixation and staining against MHC. DAPI was used to identify nuclei 
(see Materials & Methods). The analysis was focused on morphological differences between the 
TSA incubated myotubes and myotubes in the corresponding control well. Additionally, the 
number of nuclei per cell should have served as another indicator for dedifferentation. 
MHC-positive cells containing one nucleus could be observed in TSA treated as well as in 
control wells without TSA. As can be seen in Table 2, there was no difference in the frequency of 
appearance of these particular cells. Since the number of generated mononucleated MHC-positive 
progeny did not allow us to clearly attribute an effect of TSH on myotubes, we then set 5 
nuclei/cell as an arbitrary limit to monitor possible dedifferentiation effects. Even with this 
criterion, a TSA concentration of 5 ng/ml did not provoke detectable differences (see below). 
 
Since our original aim was to identify MHC-positive mononucleated cells, we examined 
myotubes incubated with varying concentrations of TSA for varying lengths of time. We 
observed that TSA concentrations of 20 ng/ml yielded significantly reduced nuclei-numbers in 
fragmented myotube-progeny and also caused dramatic changes in morphological appearance. 
However, under these conditions, cells died rapidly. 
Therefore we used lower TSA concentrations for further experiments. Although reduction of 
nuclei number in myotube fragments was not significant at 5 ng/ml, morphologically, these cells 
were clearly distinguishable from controls, indicating that same fragmentation was already 
occurring (see Fig. 10). Under these conditions, the cells remained viable and could be readily 
analysed. 
As can be seen in Fig. 10, cells without TSA treatment were branched and contained a 
considerable number of nuclei. In contrast, the cells after incubation with 5 ng/ml TSA were 
noticeably smaller and unbranched. This was particularly apparent in myotubes in the centre of 
these wells, where the cells usually accumulate after purification. 
 
The significant morphological difference to the control well and the high residual cell number 
(see Table 2) were the decisive factors to continue with 5 ng/ml TSA.  
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Figure 10.  Effect of TSA on Cells in Wells from the Same Plate  
 
(A&C) Control without TSA treatment.  
(B&D) Myotubes after exposure to 5 ng/ml TSA for 48 hours. 
 
A clear difference between the TSA treated and the untreated control myotubes can be seen. Control myotubes had 
several dozen of nuclei and a branched morphology. Big myotubes as can be seen in the control well (A, C) could 
not be found in the TSA treated well. 
The bottom picture on the right (D) shows two parts of a myotube still connected through a thin cytoplasmatic bridge 
(20x magnification).   
Blue indicates DAPI staining and green represents staining against myosin heavy chain (MHC). 
 
Photos were taken from the centres of the wells because the cells tended to accumulate there. 
Huge myotubes containing several dozens of nuclei could be detected in the untreated control 
wells, whereas the cells were remarkably smaller and contained less nuclei after TSA treatment. 
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Table 2. Cell Numbers in Control and TSA-Incubated Wells after Fixation 
 
As can be seen, with increasing concentrations and incubation times of TSA the overall amount of cells decreases 
continuously. All these experiments were carried out in 24 well plates. Purified cells were kept in 1 ml conditioned 
proliferation medium and TSA or without TSA, which served as negative control.  
n.c.: not counted  
 
Negative controls were performed for each experiment. For that purpose, cells were picked from 
the same pool of differentiated myotubes into wells of a 24-well plate. Then the cells were treated 
with variable concentrations of TSA for the same period of time. The cells in the corresponding 
control wells without TSA were kept in conditional differentiation medium for the same time. 
Subsequently, the cells were all fixed simultaneously and subjected to further analysis. 
 
4.3 Imaging fragmentation of single mammalian myotubes by time-lapse 
microscopy 
 
To find out more about the morphological changes during myotube fragmentation, time-lapse 
microscopy was applied.  
Myotubes were picked as described in Material and Methods (see Section 6.1.6). The purified 
myotubes were cultured in a 3 cm dish to fit the requirements of the time-lapse microscopy 
equipment.  
  
A motorized stage enabled a higher throughput of image-taking (up to 30 predetermined fields at 
each chosen time point). The effects induced by TSA were usually examined for four days during 
which pictures were taken every hour. During this period the C2C12 myotubes were maintained 
in differentiation medium containing 5 ng/ml TSA (see Section 4.2; except in initial experiments 
cells were kept in L15 medium as mentioned in Section 6.5.2). In contrast to the experiments 
described in section 4.2 TSA was not removed from cells after a certain period but the cells were 
incubated with TSA-containing medium for the whole procedure of time-lapse microscopy. This 
was necessary as the culture dish must not be moved during the time-lapse procedure in order to 
avoid relocation of the predetermined positions. 
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Figure 11 shows one example of a myotube that fragmentates into two smaller progeny. The first 
signs of fragmentation became evident around 12 hours after induction with TSA. The cleavage 
process continued for the next two hours and resulted in two completely separated smaller 
multinucleated myotubes. The two progeny remained quiescent for three hours. Then, one of the 
cells died while the second daughter cell died two hours later. 
In all time-lapse experiments done during this study none of the observed myotube cleavages 
resulted in mononucleated progeny nor was there any evidence that one of the cleavage 
fragments started proliferating again.  
 
A total of 90 movies from 3 independent experiments were assembled and analyzed, always 
yielding the following results:  
 
First, the myotubes elongated after induction with TSA. 
Second, the nuclei moved to opposite poles of the elongated myotube. 
Subsequently, disruption of the myotube occurred close to the centre. Unfortunately, all cells died 
after the disruption. 
In most cases the sequence of events was the same and only the time intervals of and between the 
different stages varied.  
 
Only a few myotubes did not react to the TSA treatment in the above-mentioned way. They 
stayed in a more globular shape and died at a later time point, approximately after three days.  
 
Results gained by time-lapse microscopy confirmed the decision (see Section 4.2) to continue 
experiments with a concentration of 5 ng/ml TSA. Fragmentation as has been described in Fig. 11 
could be observed frequently but never yielded progeny containing five or less nuclei.  
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Figure 11. Time-lapse Microscopy of Fragmentation of a Murine Myotube 
 
Single frame images from a myotube exposed to 5 ng/ml TSA. The arrows indicate the connecting cytoplasmatic 
bridge. Cleavage yielded progeny that were not mononucleate but had fewer nuclei than the original cell. Budding of 
a singular nucleus from the syncytium could never be observed. After the accomplishment of cleavage, the offspring 
remained quiescent for at least three hours until first signs of cell death could be observed (arrowhead).  
 
4.3 BrdU incorporation assay to evaluate if TSA treatment causes cell cycle re-
entry in C2C12 myotubes 
 
Besides cellularisation, cell cycle re-entry is another criterion of myogenic dedifferentiation 
(Duckmanton et al., 2005). 
To address this question, purified C2C12 myotubes (see Materials and Methods) were treated 
with TSA. After an incubation period of 24h the differentiation medium containing TSA was 
removed followed by incubation in conditioned proliferation medium (high serum medium) 
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containing BrdU. BrdU is a nucleotide analogue that incorporates into the DNA of cells 
undergoing S-phase. High serum medium serves as a growth factor stimulating environment, 
whereas the conditioned differentiation medium used in the previously described experiments 
served as a differentiation stimulating environment. Although preliminary experiments showed 
that conditioned differentiation medium provides a better environment for isolated myotubes 
compared to conditioned proliferation medium, in this case it was essential to stimulate cell cycle 
re-entry of the myotubes after TSA treatment to test whether the produced progeny can 
proliferate.  
In order to test if cell cycle re-entry and DNA-replication occur, cells were assayed for BrdU 
incorporation into newly synthesized DNA via immunocytochemistry. 
No BrdU incorporation could be detected independent of the length of incubation in proliferation 
medium (see Section 6.1.8), indicating that no S-phase re-entry occurred. 
 
4.4 Cell death induced by TSA treatment 
 
TSA is a proapoptotic drug and causes programmed cell death (Johnstone, 2002). For this study it 
was important to investigate whether the myotubes really fragmentized due to the influence of 
TSA. 
 
To investigate whether cell death pathways were activated in C2C12 myotubes in the presence of 
TSA, an antibody against the active form of caspase 3 was used. Caspase 3 is known to be one of 
the major regulators of cell death. 
For this purpose the same experimental procedure was applied as has been described in Section 
4.2. Accordingly, the cells were incubated with 5 ng/ml TSA for 48 hours. 
As a positive control for this experiment, cells were incubated in serum-free medium containing 
0.5 mM Staurosporine (see Section 6.1.9). Positive control results indicated that active caspase 3 
was localised next to the nucleus in apoptotic cells and to some extent overlapped with nuclear 
staining.  
Unfortunately, no conclusive results could be obtained from these experiments. To date, new 
experiments are in progress to investigate possible involvement of TSA-induced apoptotic 
pathways in dedifferentiation. 
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4.5 Inductive effects of TSA on A1 myotube fragmentation 
 
Upon injection into a regenerating stump, cultured A1 myotubes undergo cellularisation and 
contribute to the mesenchymal cell mass, also referred to as blastema (Lo et al., 1993).  
In order to test the ability of A1 myotubes to cellularise in vitro, A1 myotubes were isolated (see 
Material and Methods) and incubated with TSA. Incubation periods of 24, 48 and 72 hours, 
respectively, were chosen while the concentration of 5 ng/ml TSA remained constant.  
As has been described in Section 4.2, fragmentation of murine myotubes could be observed after 
incubations in 5 ng/ml TSA for 48 hours. Similar effects were expected in newt myotubes, with 
the general difference that responses to exogenous signals seem to be delayed in newt cells. For 
this reason, the longer incubation time of 72 hours was applied.  
The effects of TSA on A1 myotubes were similar but not identical to those observed on murine 
C2C12 cells. Fragmentation did occur but was not as frequent as in murine myotubes, whereas 
the rate of cell death was increased. The residual cells were examined for MHC and number of 
nuclei. Again, no significant amount of mononucleated cells above background level could be 
detected (see Table 2). 
Moreover, morphological changes could be detected in A1 myotubes in response to TSA. The 
cells elongated and migration of the nuclei into the newly formed extensions took place. 
However, the final step of fragmentation, budding, did not occur (see Fig. 12). For this reason, 
the morphological difference between TSA-incubated newt myotube cultures and the cells of the 
untreated control wells was not very conspicuous. 
Accordingly, the results gained of TSA-induced A1 myotubes significantly differ from the results 
obtained of murine myotubes as described in Section 4.2. 
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Figure 12. Effect of 5 ng/ml TSA for 48 Hours on A1 Myotubes 
 
(A&C) Control well 
(B&D) TSA-incubated cells 
 
Panels A&B show representative myotubes from the centre of control and TSA-treated well, respectively. In contrast 
to C2C12 myotubes (see Fig. 10), there is no obvious difference between them.   
Panels C&D show myotubes where nuclei migrated into cytoplasmatic extensions. These extensions were still 
connected to the cells (indicated by arrows). This migration of nuclei was detected in control wells as well as in TSA 
treated wells.   
Blue indicates DAPI staining, yellow represents staining against myosin heavy chain (MHC). 
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4.6 Microinjections of non-isolated A1 myotubes and subsequent incubation with 
TSA 
 
In order to circumvent the stress imposed on the cells during purification, a new method was 
applied (Morrison et al., 2007). 
Thereby, the differentiated cells were traced expressing various molecules as described in Section 
6.3. The cells were microinjected with high molecular weight dextran or plasmids carrying the 
red fluorescence protein (RFP) as a reporter gene or the fusion protein H2B-YFP (histone 2B-
yellow fluorescence protein). Refer to Section 6.3.3 for detailed experimental settings. This 
method has not been applied to newt myotubes before. The advantage over previous experimental 
settings was that the differentiated cells did not need to go through an extra purification step, 
which is challenging for their survival.  
As expected, the H2B-YFP stained the nuclei whereas dextran and the RFP stained the cytoplasm 
of the myotubes.  
With the applied microscopic analysis it was not possible to examine if all the injected cells were 
traced. Nevertheless, the observed traced cells were sufficient to determine the effect of TSA on 
the differentiated non-isolated myotubes.  
Up to 150 ng/ml TSA was used in this experiment (see Material and Methods). As muscle cells 
exhibit contact inhibition when growing too dense (Tanaka et al., 1997) these higher TSA 
concentrations were used in order to countervail this phenomenon. 
 
However, despite the high TSA concentrations no fragmentation/dedifferentiation could be 
observed. All examined positively stained myotubes (surrounded by unstained myotubes or 
myoblasts) remained in their natural conformation or changed to a more globular shape with 
increasing TSA concentrations. None of the TSA concentrations used induced an event that could 
be interpreted as budding of smaller cell progeny, and not even the formation of cytoplasmatic 
extensions could be observed. 
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5. Discussion 
 
5.1 Histone H3 lysine 9 (H3K9) methylation and regeneration 
 
So far, all results gained in studies on limb regeneration predict progeny of differentiated cells 
close to the amputation plane to form a mesenchymal cell mass referred to as blastema. It seems 
that a dedifferentiation process yields uncommitted cell offspring that possesses stem cell-like 
properties. To date, it is a matter of debate which progenitors and in which location within the 
stump tissue contribute to the dedifferentiation process. Dermal fibroblasts (Gardiner et al., 1986) 
might be involved as well as muscle cells, chondrocytes, Schwann (Ferretti and Brockes, 1991) 
cells or satellite cells (Morrison et al., 2006). Neither of these cell types can be excluded while on 
the other hand it is not proven if they are involved in the process at all. To gather more 
information concerning which cells in which location within the stump tissue participate in the 
dedifferentiation process, studies have been executed on the basis of chromatin modifications. 
Chromatin modifications can lead to an altered gene expression, which is required for a cell to 
acquire new properties (Jenuwein and Allis, 2001). Furthermore, altered gene expression is a 
prerequisite of dedifferentiation. The emphasis in the initial phase of this experiment was on the 
detection of a general alteration in histone modification in the stump tissue without focusing on a 
specific cell type. The intention of the study was to identify progenitors of the blastema.   
For a better detection of all cell types, tissue sections of 6 µm thickness were chosen, as they 
proved to be the most suitable for this purpose in independent studies in our lab. 
Cultured satellite cells contribute to the regenerate when injected intramuscularly before 
amputation (Morrison et al., 2006). Therefore, we wanted to investigate whether satellite cells are 
subjects of chromatin alterations during the initial steps of regeneration as well.  
 
Generally, histone H3K9 methylation is associated with transcriptional repression (Nakayama et 
al., 2001). This study was partly aimed at the identification of cells that contribute to regenerating 
tissue on the basis of histone H3K9 de-methylation. H3K9 de-methylation is usually associated 
with relaxed chromatin allowing access of transcription factors (Klose et al., 2006; Loh et al., 
2007). The de-methylated state, i.e. the loss of methylation was to be detected by specific 
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antibodies comparing tissue sections of regenerating and normal limb tissue. A reduction of 
histone H3K9 tri-methylation, usually a sign of very dense chromatin, could already be detected 
3 days after limb amputation (see Table 1). Furthermore, a loss of histone H3K9 di-methylation, 
correlating with a less tight packing of chromatin as observed in tri-methylation, became apparent 
10 days after tissue removal (see Fig. 8). A possible explanation for the observed phenomenon 
could be that reversion of tight repression in terms of histone H3K9 tri-methylation was followed 
by reversion of the chromatin attachments at specific loci at later time point in regeneration.  
 
The most apparent differences between tissue sections 3 and 10 days post amputation and normal 
limb tissue sections can be assigned to cells next to the amputation plane and to the subepidermal 
region at the blastema-stump-boundary. So far, the obtained results represent the proposed niches 
for progenitor cells in general (see above). At this point of the project, however, no accurate 
specifications of the involved cell types can be made. However, the results of this diploma work 
demonstrate that tissue sections from early blastema stained for histone H3K9 tri- and di-
methylation showed very weak staining. This could indicate a reversion to the uncommitted state. 
 
An interesting observation was made within observed nuclei. On normal limb tissue- and on 3-
days-post-amputation tissue sections stained against histone H3K9 di-methylation a zone within 
the nuclei appeared brighter compared to the surrounding chromatin (see Fig. 7).  Possibly, these 
bright chromatin zones represent a heterochromatic part containing genes for regeneration. This 
hypothesis is consistent with a recent report of Murakami et al., (2007). Accordingly, 
regeneration-specific genes could be mapped to the short arm of chromosome 7. At the later time 
point of 10 days post amputation where a noticeable loss of staining intensity was observed could 
indicate the transcriptional activation of the involved genes. The zone possibly corresponds to the 
region of the short arm of chromosome 7 (Murakami et al., 2007). 
 
The same staining technique using the same antibodies for histone H3K9 tri- and di-methylation, 
respectively, yielded no results when applied to wound epidermal cells. The signal intensity 
resembled normal limb tissue in tissue sections taken 3 days as well as 10 days after amputation. 
The reason for this is still unclear. Post-amputational wound closure is mediated by rapid 
movement of epidermal cells from the margin of the injury over the wound. 9 hours after limb 
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tissue truncation the wound surface is closed by the migrated epidermal cells. During cell 
migration, a transition of heterochromatin nuclei (according to the situation before trauma) to 
nuclei containing more euchromatin can be observed in the involved epidermal cells (Repesh and 
Oberpriller, 1980). Furthermore, this newly established epidermis, referred to as wound 
epidermis, is thought to be a signalling centre for the consecutive regeneration process. 
One explanation for our negative staining result could be that 3 days post amputation (which was 
the earliest time point of taking tissue sections) the chromatin alterations in epidermal cell nuclei 
are already reverted into their pre-amputation configuration. As wound closure by epidermal cells 
is already completed 13 hours after limb amputation (Repesh and Oberpriller, 1978) this seems to 
be not only possible but reasonable.  
Another reason might be a different regulation of chromatin alterations in epidermal cells. 
Histone acetylation instead of histone methylation could be used as a control mechanism for the 
accessibility of regulatory gene sequences. 
To date, the mechanisms that alter epidermal chromatin conformation remain unclear. 
 
 
5.2 Trichostatin A causes myotube fragmentation 
 
Stimulation of terminally differentiated newt myotubes with 12% FCS containing medium leads 
to cell cycle re-entry (Tanaka et al., 1997) and associated acteylation of histone H4 lysine 12 
(H4K12) (Simon A., unpublished data) (see Fig. 13). Therefore, experiments in our group (Lööf 
S., unpublished data) were carried out to examine if the inhibition of histone deacetylases 
(HDAC) leads to cell cycle re-entry as well. For that purpose, newt and murine myotubes were 
incubated with Trichostatin A (TSA), which inhibits class 1 and class 2 HDACs, and Valproic 
acid (VPA), which inhibits preferentially class 1 HDACs. Analysis of the results of these initial 
treatments revealed an unexpected outcome: the myotubes developed constrictions between the 
nuclei giving them a beads-on-a-sting appearance. Interestingly, HDAC inhibitor treatment had a 
greater impact on murine myotubes than on newt myotubes (see Fig. 14). Furthermore, 
quantifications of mononucleated, MHC-positive cells demonstrated a significant difference 
between treatments with TSA and VPA. The percentage of mononucleated, MHC-positive cells 
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was up to four times higher in TSA-treated cell samples compared to VPA treatment (see Fig. 
14). This was an indirect measure of cellularisation occurring.  
In control experiments it was shown that HDAC inhibition does not induce MHC expression in 
myoblasts. This result led to further experiments with HDAC inhibitors. Considering these 
results, it was decided to investigate the effects of TSA on murine myotube cellularisation in 
more detail. 
 
               Phase                                H4K12                               BrdU                                Merged 
    
 
Figure 13. Cell Cycle Re-entry of Newt Myotubes Correlates with Histone Acetylation 
 
Myotubes were cultured in proliferation medium, which causes cell cycle re-entry in newt myotubes accompanied 
with histone H4 lysine 12 (H4K12) acetylation (arrow). Quiescent nuclei are negative for histone H4K12 acetylation 
(arrowhead). 
(Adopted from Dr. Andras Simon, Karolinka Institutet, Sweden) 
 
 
Figure 14. Statistical Evaluation of the Comparison 
of Trichostatin A (TSA) and Valproic Acid (VPA) 
treatment on Murine- and Newt Myotubes. 
Columns represent percentage of mononucleated 
MHC-positive cells.  
 
(Adopted from Sara Lööf, Karolinka Institutet, 
Sweden)                                                                                 
 
 
Thus, the TSA incubation studies were concentrated on murine cells. Another very important 
reason was the relevance in the field of regenerative medicine. Due to the relatively close 
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phylogenetic relationship of mouse and men it is possible that studies on murine cells can 
improve the knowledge of the plasticity of the differentiated state in humans as well. This would 
lead to a better understanding of tissue regeneration and cancer appearance and could offer new 
strategies for therapeutic treatments as a long term goal.  
The initial experiments were carried out with mesh purified myotubes (see Material and 
Methods) resulting in high contamination with residual myoblasts which was unsuitable for the 
intended experiments. Therefore, it was necessary to get very pure myotubes. This could be 
achieved by the picking procedure (see Material and Methods). After picking the myotubes, 
cultures contained very little myoblast contamination. With these cultures the previously 
described experiments were repeated. The challenge thereby was that the myotubes were 
transferred to a totally new microenvironment by picking, as the myotubes were now sparsely 
seeded without contact to each other. In comparison to mesh purified cell cultures, the overall 
number of myotubes per dish was considerably reduced after purification by picking. The 
evaluation of the experiments was additionally aggravated by the fact that myotubes purified by 
picking are quite instable in culture and have an average lifespan of only five to seven days. It 
was not known whether these altered conditions would have an effect on the results of the 
experiments. 
The initial TSA-incubation studies on mesh purified myotubes identified 100 ng/ml as an optimal  
concentration of TSA for the examination of cellularisation-plasticity of terminally differentiated 
cells, such as myotubes. Due to the altered culture conditions after picking-purification the TSA 
concentration was reduced to 50 ng/ml. The impact of TSA on the myotubes was analysed in 
comparison to control cell populations that were not incubated with TSA. As a considerable 
number of cells died in the TSA-treated cell populations, the concentration of TSA was then 
considerably reduced. 
Although the number of mononucleated MHC-positive cells did not increase compared to the 
control well (see Table 2), there was a difference in the overall cell size. The cells in the TSA 
incubated wells were smaller and contained less nuclei. Unfortunately, a certain fixed number of 
nuclei per cell as a reliable indicator of dedifferentiation could not be defined. The arbitrarily 
defined amount of five or less nuclei per cell revealed no difference between TSA treated and 
control wells. 
51 
Increased concentrations of TSA together with longer incubation times result in increasing 
amounts of MHC-positive cell progeny containing fewer nuclei compared to untreated cell 
populations (as indicated by results summarised in Table 2). On the other hand, the overall cell 
number decreased dramatically the higher the TSA concentration was. Best results with respect to 
residing cells were achieved at a concentration of 5 ng/ml TSA for 48 hours. 
Whereas the number of cells containing five or less nuclei was not increased by incubation with 5 
ng/ml TSA for 48 hours, the effect on cell size and morphology was considerable (see Fig. 10). 
Thus, all further experiments were carried out with 5 ng/ml TSA for 48 hours if not indicated 
otherwise. 
 
To date it is unknown in which way and to which extent cellularisation and cell cycle re-entry 
depend on each other (see Fig. 3). Nevertheless, both events occur during the reversal of the 
differentiated state. BrdU incorporation experiments should help to elucitate this 
interdependence. The results obtained so far suggest that fragmentation occurs without cell cycle 
re-entry as no MHC- and BrdU- double positive cells could be detected. This observation was 
confirmed by results of time-lapse studies where the budding of a single nucleus from the 
syncytium could never be observed. 
The budding of a single nucleus would imply that this nucleus has become mitotically active. 
This may reflect the exit from the “differentiated environment” of the syncytial myotube to 
produce mesenchymal-like cells exhibiting stem cells properties during limb regeneration. 
This result was contrary to the initial considerations where an impact of TSA exclusively on cell 
cycle re-entry was expected. When fragmentation occurs in the absence of cell cycle re-entry 
(and further in the absence of a supposed nuclear reprogramming), the observed event of 
fragmentation under TSA influence is supposably caused by the inhibition of HDAC 6. Zhang et 
al., (2003) reported that HDAC 6, a member of class 2 HDACs, is associated with the 
microtubule cytoskeleton (Zhang et al., 2003). Therefore, inhibition of HDAC 6, which is a target 
of TSA but not VPA, in muscle cells may lead to instability of the microtubule cytoskeleton and 
promote fragmentation into smaller progeny. This would also explain the greater impact of TSA 
on cellularisation described above. Furthermore, this hypothesis is consistent with the results of 
Duckmanton et al., (2005). Their study on fragmentation of myotubes was based on the use of a 
small triazine compound. Accordingly, the mere disruption of the microtubule cytoskeleton 
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causes cellularisation. The inhibition of protein synthesis by 10 µM anisomycin did not alter this 
outcome and neither was BrdU incorporated during the process of cellularisation. However, it 
remains unclear to which extent the different results of Duckmanton et al., (2005) can be 
compared to our data because different murine cell types were used for each experiment. 
Thus, nuclear reprogramming is not necessary for fragmentation. Consequently, one possible way 
how fragmentation/cellularisation can be achieved was identified whereas the underlying 
regulatory mechanisms remain unclear. However, fragmentation/cellularisation is only one aspect 
of dedifferentiation as indicated in Fig. 4. 
 
The results from time-lapse microscopy were consistent with the results gained from classical 
static microscopy. None of the 90 movies showed the formation of mononucleated offspring. The 
observed results did not vary, even when different media were used (see Material & Methods). 
One reason for this result could be that the purified myotubes adopted an unnatural conformation. 
In vivo, myotubes are elongated, roundish and unbranched with pointed tips at each end. In vitro, 
they became flattened, broad and branched. Maybe the use of different culture conditions, e.g. 3D 
matrix, or even a different cell type, e.g. pmi28 (Duckmanton et al., 2005) would render it 
possible to study the process of fragmentation in a situation more similar to the in vivo state. It is 
possible, that the cells in that case would react differently to the TSA treatment and budding of 
mononucleated progeny could occur.   
As all cell progeny died after a transient resting period we wanted to investigate whether 
apoptosis or necrosis occurred following fragmentation. This question was interesting for two 
resons: 
First, if the cells died necrotically then fragmentation was harmful to cultured myotubes. 
Second, if the cells died by the apoptotic mechanism, further questions had to be answered: Was 
apoptosis the consequence of fragmentation? Or were apoptotic pathways already active before 
the fragmentation process set in? 
In the case of an active apoptotic machinery before the start of fragmentation it would be 
interesting to know if certain apoptotic mechanisms are essential for the process of 
dedifferentiation. This hypothesis is based on observations indicating that apoptotic pathways, in 
particular active caspase 3, seem to be important to maintain the pluripotent potentials of stem 
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cells (Zwaka et al., 2005). Due to the fact that this experiment was in its initial phase by the end 
of this diploma work, no conclusions could be drawn, so far. 
However, the data demonstrated that muscle cells undergo fragmentation in response to TSA. 
Because of the methodology used in this study, namely the manual picking of individual 
myotubes (instead of the commonly used filter method; see Material and Methods), we could 
show that fragmentation sets in already at very low concentrations of TSA. This points to a direct 
involvement of chromatin structural changes in the early aspects of dedifferentiation and provides 
opportunity for further detailed investigation of the dedifferentiation mechanism.   
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6. Material and Methods 
 
6.1 Cell culture 
 
6.1.1 Cell culture systems 
 
C2C12-G myoblasts (mouse myogenic cell line derived from satellite cells) constituted the 
system to study the process of dedifferentiation of mammalian cells. Only cells with a low 
passage number were used. For high passage number derived cells have a reduced ability to 
differentiate, which is the main prerequisite for using them in subsequent experiments. 
 
In order to study the urodele dedifferentiation process in vitro, A1 cells were used. Cells were 
obtained from Brockes, Jeremy P., University College London. Passage numbers of these cells, 
compared to the C2C12 cells, were much higher, around seventy.  
 
Both cell types were stored in liquid nitrogen until usage. 
 
6.1.2 Thawing of A1 and C2C12 cells 
 
The thawing procedure for A1 and C2C12 cells is the same except that A1 cells require a 25˚C 
environment whereas C2C12 cells require a 37˚C environment. Briefly, cells were frozen in 
proliferation medium containing 10% dimethyl sulfoxide (DMSO). Liquid nitrogen frozen cells 
were thawed in a water bath. The thawed cells were transferred into fresh pre-warmed 
proliferation medium and subsequently spun down at 350 rpm for 10 minutes. The cell pellet was 
resuspended in 10 ml proliferation medium and seeded in a 165 cm2 flask, which was already 
filled with 10 ml of the corresponding proliferation medium. Prior to plating A1 cells, 165 cm2 
flasks were precoated with 1% Gelatine (Sigma-Aldrich). 
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6.1.3 Culture conditions and passaging of C2C12 myoblasts 
 
Cells were grown until they reached a confluency of around 60%. Depending on the experimental 
progress cells were passaged 1:5 to 1:10. Afterwards, media was removed, the cells rinsed twice 
with 10ml of prewarmed PBS and then incubated with 1.5 ml of prewarmed Trypsin EDTA for 5 
minutes at 37˚C. Upon cell detachment, Trypsin EDTA was neutralized by adding 8.5 ml 
proliferation medium. 1 or 2 ml of cell suspension were seeded out in a 75 cm2 flask with 9ml of 
proliferation medium. 
 
C2C12 proliferation medium: DMEM ≥ 12% foetal bovine serum (FBS) 
DMEM (+ 4500mg/l Glucose, + L- Glutamine, + Pyruvate) (Gibco) 85.5% 
FBS (Gibco) 12.5% 
Penicillin/Streptomycin (Gibco) 1% 
GlutaMAX I (100×) (Gibco) 1% 
 
C2C12-Trypsin  
Trypsin EDTA (10×) (Gibco)  10% 
PBS 90% 
 
PBS: 1× D- PBS (phosphate buffered saline) (Gibco) 
Had been used in all experiments. 
 
6.1.4 Culture conditions and passaging of A1 myoblasts 
 
A1 myoblasts were passaged in the same way as C2C12 cells. Due to the decreased growth rate 
of A1 cells, the need for passaging was not as frequent as for C2C12 cells. Cell culture flasks 
were coated with 1% Gelatine as described previously. After trypsinisation, 5ml of cell 
suspension were transferred to a 162 cm2 flask containing 20 ml of A1 proliferation medium. 
 
Media and solutions used in A1 cultures were diluted with 24% ddH2O due to their lower 
osmolarity. 
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A1 proliferation medium: AMEM (amphibian minimal eagle medium) ≥ 12% FBS 
MEM (+ Earle’s, - L- Glutamine) (Gibco) 60.5% 
FBS (Gibco) 12.5% 
Penicillin/Streptomycin (Gibco) 1% 
GlutaMAX I (100×) (Gibco) 1% 
Insulin (1 mg/ml) (Sigma) 1% 
ddH2O 24% 
 
A1-Trypsin  
Trypsin EDTA (10×) (Gibco) 10% 
PBS 66% 
ddH2O 24% 
 
A1-PBS 
1× PBS (Gibco) 76% 
ddH2O 24% 
 
6.1.5 Differentiation assay 
 
In order to study the dedifferentiation of terminal differentiated myotubes the C2C12 and A1 
myoblasts had to be fused to result in multinucleated cells expressing late muscle differentiation 
markers like myosin heavy chain (MHC) and muscle creatine kinase (MCK). In culture this could 
be achieved by withdrawal of serum on confluent progenitor cells (myoblasts). 
Basically, the procedure is the same for both cell-types being used. Differences arose from the 
different lineage. Briefly, cells were grown on cell culture dishes, coated with 1% gelatine in the 
case of C2C12 cells. For A1 cells coating was done with Laminin (Sigma-Aldrich) (diluted 1:100 
in serum-free medium) for at least 1 hour and 1% gelatine. 
When they reached confluency, the proliferation medium was removed. Cells were rinsed once 
with differentiation medium and subsequently cultured in differentiation medium.  
Differentiation to get terminally differentiated C2C12 cells took four days. Within this time the 
differentiation medium was changed with a fresh one every day. The removed differentiation 
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medium was filtered through a syringe filter with a 0.20 µm SFCA membrane (Corning) and 
saved as conditioned medium. 
A1 cells corresponding to their slower cell physiology took six days to yield in terminally 
differentiated myotubes. The differentiation medium was not changed during that time. 
 
Differentiation medium of C2C12 cells: DMEM 1% horse serum 
DMEM (+ 4500mg/l Glucose, + L- Glutamine, + Pyruvate) (Gibco)  97%  
Horse Serum (Gibco) 1% 
Penicillin/Streptomycin (Gibco) 1% 
GlutaMAX I (100×) (Gibco) 1% 
 
Differentiation medium of A1 cells: AMEM 0.5% FBS 
MEM (+ Earle’s, - L- Glutamine) (Gibco) 72.5% 
FBS (Gibco) 0.5% 
Penicillin/Streptomycin (Gibco) 1% 
GlutaMAX I (100×) (Gibco) 1% 
Insulin (1 mg/ml) (Sigma) 1% 
ddH2O 24% 
 
6.1.6 Purification of myotubes 
 
i) Picking assay  
 
For C2C12 myotubes and A1 myotubes the procedure is the same, except for the cell-type 
specific mediums. 
In order to yield the highest possible purity of myotubes the picking approach was used. Picking 
means that the myotubes got aspired by a glass-capillary from a cell suspension. The cell 
suspension contained both myoblasts and myotubes. It was possible to perform the assay 
manually because the size difference between mononucleate myoblasts and multinucleate 
myotubes was obvious.  
Certain preparations were necessary before the actual picking procedure: 
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Coating of 24 well plates or 35 mm dishes, dependent on the consecutive application, with 
fibronectin (Sigma-Aldrich) (1:100 in serum-free medium) for at least 1 hour and 1% gelatine. 
Furthermore, 60 mm dishes, from where the myotubes were picked, and the glass-capillaries into 
which the myotubes got aspired were coated with horse serum to prevent the myotubes attaching 
to their surface. This is important because the myotubes were meant to be transferred into the 24 
well plates or 35 mm dishes mentioned above. The horse serum coated 60 mm dishes were stored 
with the conditioned differentiation medium (50% removed sterile filtered differentiation 
medium with 50% fresh differentiation medium) in the incubator until being used. 
Before the picking procedure, myoblast differentiation was carried out in 12 well plates as 
described previously. One well of myotubes from the 12 well plate was trypsinized. Detachment 
was observed under the microscope. In the case of C2C12 myotubes this was important because 
myotubes detach faster than the surrounding myoblasts. However, there was no difference in the 
detachment of A1 myotubes compared to A1 myoblasts. Once the trypsinisation was sufficient in 
terms of myotubes being fully detached, cells were transferred to one 60 mm dish and stored in 
the incubator. From this point on a time window of 30 minutes was left to pick the myotubes 
until the death rate increases significantly. Purified myotubes were transferred into fibronectin 
and gelatine coated wells (see above), which contained conditioned differentiation medium.  
 
A short description of the “picking-apparatus”: The tip of the glass-capillary was trimmed to an 
appropriate diameter with a sterile scissor under a microscope. Now the capillary got fixed to a 
support. The support was placed next to an inverted microscope (Nikon Corp.) that was used for 
visualisation of the cell suspension and the tip of the glass-capillary during the picking procedure. 
Further the support was adjustable in all three space dimensions, manually. A flexible tube served 
as a connection between the glass capillary and a micro-volume syringe (Hamilton).  
Once the cell suspension was transferred to the 60 mm horse serum coated dish (see above) the 
actual purification could start. The dish was placed under the inverted microscope and the plane 
of focus was adjusted to the level of the floating cells. Afterwards the tip of the glass-capillary 
was dipped into the medium of the cell suspension. The tip was placed into the centre of the 
visual field of the microscope and just above the floating cells. At that position the tip and the 
aspirated cells could be seen clearly. For aspiration of the cells the undertow from the connected 
micro-volume syringe was used.  
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ii) Mesh purification of myotubes (procedure is the same for C2C12- and A1 myotubes) 
 
Again, this technique used the morphological feature of different size from myotubes to separate 
them from their progenitors. But the success rate in terms of purity compared to the picking assay 
was much lower. 
For this assay, myoblasts were grown to confluency in 100 mm dishes scored with a scalpel to 
form a grid. This prevented myotubes from becoming too large. After the incubation time in the 
corresponding differentiation medium myotubes were purified as follows. Basically, cells were 
trypsinized as described above and the cell suspension was sieved through a 100 µm nylon cell 
strainer (BD Falcon). This step removed the big clumps of cell aggregations that were left after 
treatment with Trypsin. The supernatant containing myotubes as well as mononucleated 
myoblasts, was sieved through a 20 µm mesh (Spectrum Laboratories). In this step the myotubes 
were retained on the mesh whereas the small myoblasts passed through. The myotubes on the 
mesh were washed off by rinsing the mesh in a dish containing conditioned differentiation 
medium and had been coated before with horse serum, as mentioned previously. The obtained 
cell suspension was further separated on 24 well plates or 35 mm dishes coated with fibronectin 
and gelatine. 
In almost all experiments done during the diploma thesis the picking assay was used. 
 
6.1.7 Trichostatin A (TSA) treatment approach 
 
Trichostatin A (Sigma-Aldrich) is a histone deacetylase (HDAC) inhibitor that inhibits the 
members of class 1 and class 2 HDACs.  
Myotubes, which were isolated by picking, were allowed to attach to the substrate over night. 
Approximately 50% of the purified myotubes died during the first night. That was presumably an 
effect of stress caused by the picking procedure. Therefore, medium with the detached dead 
myotubes was removed and replaced by fresh, conditioned differentiation medium (see Section 
6.1.5). TSA was added to the fresh, conditioned medium. Concentrations ranging from 5 ng/ml to 
150 ng/ml were used.  
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6.1.8 5-Bromo-2’-deoxyuridine (BrdU) labeling assay 
 
Incorporation of BrdU into DNA occurs during the S-phase of the cell cycle. For that reason 
BrdU incorporation can be used as a measurement to see if the cells have traversed G1/S-phase 
transition and started to replicate their genome.  
In the approach used in this study, BrdU labelling was done after a previous TSA treatment. TSA 
concentration of 50 ng/ml was used. After an incubation period of 24 hours the TSA containing 
conditioned differentiation medium was replaced. Cells were washed once with medium 
containing 1% horse serum to get rid of the remaining TSA. Subsequent incubation was done 
with conditioned proliferation medium (75% recycled, sterile filtered proliferation medium with 
25% fresh proliferation medium) containing 10 µM BrdU for 8, 16 and 24 hours, respectively, 
until fixation.  
 
6.1.9 Measurement of active caspase 3 
 
Detection of active caspase 3 in cells serves as indicator for apoptosis. Apoptosis is referred to as 
programmed cell death. A cascade of apoptotic-specific enzymes has to become activated to yield 
in apoptosis. One of these enzymes is caspase 3 which capture a central role within the apoptotic 
enzyme cascade. That means, if the active form of caspase 3, referred to as p17, is detected the 
cell is committed to undergo cell death. 
In this study active caspase 3 identification was used to assay if incubation of C2C12 myotubes 
with TSA leads to cell death. For that purpose myotubes were purified as described in Section 
6.1.6 with the picking procedure. The following day, cells were incubated with 5 ng/ml TSA for 
48 hours and fixed afterwards.  
For positive control cells were isolated in the same way. On the next day, cells were washed once 
with medium without serum to get rid of the remaining serum. Subsequently, cells were 
incubated in medium without serum containing 0.5 mM Staurosporine (Sigma-Aldrich) for 4 
hours till fixation.     
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6.2 Immunocytochemistry 
 
This method makes use of an antibody specific for the antigen of interest (primary antibody) in 
conjunction with a labeled second antibody (hereafter referred to as secondary antibody). This 
secondary antibody binds the primary antibody and can either be linked to a fluorophore directly 
or to biotin, which can be visualized via amplification of the signal. In both cases the goal is to 
make the primary antibody and hence the molecule/protein of interest visible. 
 
Within the time of the thesis, according to the primary antibody used, different protocols were 
used. But in each case the secondary antibody was an Alexa Fluor conjugated antibody 
(Molecular Probes) raised in goat against various sources of primary antibody (Alexa Fluor 488, 
Alexa Fluor 546 and Alexa Fluor 633). 
 
i) Myosin heavy chain (MHC) immunocytochemical staining 
 
Purified, in TSA incubated myotubes (see Sections 6.1.6 and 6.1.7) were washed once with 1× 
PBS and prefixed to the bottom of the dish with 2% paraformaldehyde (PFA)/PBS for 1 minute 
at room temperature (RT). Prefixed cells were washed once with PBS followed by 5 minutes 
incubation in -20˚C methanol. The methanol treatment is thought to fix and permeabilize the 
cells. Afterwards cells were washed twice with PBS and incubated in blocking buffer (10% goat 
serum in PBS) for 10 minutes. As primary antibody, a mouse monoclonal anti-myosin heavy 
chain IgG (MF-20; Developmental Studies Hybridoma Bank) 1:200 in blocking buffer was used. 
Incubation was done on a shaker over night at 4˚C. Next the cells were washed three times for 5 
minutes in blocking buffer. This was followed by the incubation with the secondary antibody 
(1:500 in blocking buffer) on a shaker for 1 hour at RT. Afterwards, the cells were washed with 
blocking buffer for 10 min. The nuclei got stained with 4’, 6-diamidino-2-phenylindole (DAPI) 
(Sigma-Aldrich) at a concentration of 10 µg/ml for 2 minutes. Finally the cells were rinsed once 
with PBS and afterwards stored in PBS at 4˚C.  
 
 
 
62 
ii) MHC and BrdU double immunocytochemical staining 
 
Cells exposed to TSA followed by BrdU incubation (see Section 6.1.7 and 6.1.8) were washed 
once with PBS and prefixed with 2% paraformaldehyde/PBS for 20-30 seconds at RT. 
Subsequently, the cells were washed once with PBS and fixed and pre-permeabilized for 5 
minutes in -20˚C methanol. Again they were rinsed with PBS. In order to permeabilize the 
nuclear envelope to allow for BrdU staining, cells were treated with 2M HCl for 10min. 
Afterwards cells got washed three times with PBS and were incubated for 10 minutes in blocking 
buffer (10% goat serum in PBS). Incubation of primary antibody rat monoclonal anti-BrdU IgG 
(AccuSpec) 1:200 and primary antibody mouse monoclonal anti-myosin heavy chain IgG (MF-
20; Developmental Studies Hybridoma Bank) 1:200 in blocking buffer was done simultaneously 
on a shaker over night at 4˚C. The primary antibodies were washed off by rinsing the cells with 
blocking buffer three times for 5 minutes. As secondary antibodies Alexa Fluor 488 goat anti-
mouse and Alexa Fluor 546 goat anti-rat, 1:200 in blocking buffer were used, respectively. They 
were incubated for 1 hour at RT. Then cells got washed for 10 minutes in blocking buffer. The 
nuclei were stained in the same way as described for single MHC staining (see above). Staining 
was completed by rinsing once in PBS. Cells were stored in PBS at 4˚C until analysis. 
 
iii) Immunocytochemical staining against activated caspase 3 
 
Myotubes cultured with Staurosporin in medium without serum (positive control) or TSA (see 
Section 6.1.9) were carefully washed once with PBS. Subsequently, myotubes were fixed in 4% 
paraformaldehyde/PBS for 20 minutes at RT. Paraformaldehyde/PBS was removed by washing 
the cells for 30 minutes in PBS. The myotubes were permeabilised with 0.1% Triton X-100 
(Sigma) in 0.1% tri- Sodium citrate dihydrate (Merck) for 3 minutes on ice. The citrate method 
removes soluble proteins from the cell nuclei. Afterwards, cells were washed in PBS three times 
for 5 minutes. Then the cells got blocked in blocking buffer (2% BSA in PBS) for 2 hours. 
Primary antibody rabbit polyclonal anti-human/mouse caspase 3 active IgG (R&D Systems) was 
used at a final concentration of 0.3 µg/ml in blocking buffer, incubated over night at 4˚C. 
Washing three times in PBS for 5 minutes followed. Secondary antibody staining using again 
Alexa Flour conjugated antibody (1:400 in blocking buffer) was done for 1 hour at RT. Nuclei 
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were stained with DAPI (Sigma-Aldrich) 10 µg/ml for 2 minutes. After rinsing once in PBS cells 
were stored in PBS at 4˚C. 
 
6.3 Lineage tracing by microinjection of A1 myotubes 
 
Microinjections were performed in order to trace myotubes.  
 
In general, lineage tracing is the method of choice to mark and follow a specific type of cells e.g. 
during development. This can either be achieved by transfection of a zygote with a reporter gene 
that is under the control of a cell type specific promoter. In this case the reporter gene is only 
expressed in cells/tissues where the promoter is activated by transcriptional activators specific for 
the identity of the cells/tissue. 
Or tracing is done in already differentiated cells. The challenge at this is that the nuclear envelope 
is continuously intact. To overcome this, cells can either be infected with a lentivirus that carries 
the reportergene or the DNA is directly injected into the nucleus. 
Furthermore, specific molecules with self fluorescing properties or attached to fluorochromes can 
be injected into the cytoplasm to mark the cell of interest. 
 
In this study different dyes and staining methods were applied, that shared a common 
modification, namely the attachment of a nuclear localisation signal (NLS) to traverse the nuclear 
envelope. 
The NLS peptides used were a simian virus 40 T antigen NLS (NH2 –PKKKRKVEDPYGGC-
COOH) and polyomavirus large T antigen NLS (NH2 –CGYGVSRKRPRPGC-COOH). Both 
were synthesized by Thermo Electron Corporation (Germany). Previous independent experiments 
with both peptides confirmed their functionality. 
 
6.3.1 High molecular weight dextran 
 
Dextrans are hydrophilic polysaccharides and characterized by good water solubility, low toxicity 
and relative inertness. The crucial feature for the performed experiment was that it could not 
cross the plasma membrane and stain surrounding cells. The dextran was already conjugated to a 
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fluorescein with approximate absorbance maximum at 496 nm and approximate fluorescence 
emission maxima at 524 nm (Molecular Probes) and was further modified by a Sulfo-SMCC 
linker (Pierce) with a covalently attached NLS (see above). This yielded the final construct that 
got injected into the A1 myotubes. 
 
6.3.2 Reporter gene expressing plasmids 
 
The second tracing approach applied comprised the injection of Plasmids that carried reporter 
genes. Two different types of constructs were used. Both had a CMV promoter to force 
expression of the reporter gene (see Fig. 15). While one construct carried a red fluorescence 
protein (RFP), the second contained a yellow fluorescence protein (YFP) tagged to a Histone 2B 
(H2B) - sequence. The RFP-protein stained the cytoplasm whereas the YFP-H2B-construct 
stained the nuclei because the fusion-protein got integrated into the nucleolus. 
Both plasmids were modified with a NLS sequence, whereas the NLS peptide was not covalently 
linked to the plasmid. The approach applied, used a phenomenon that appears when NLS 
peptides are in a much higher concentration compared to the plasmid. In this case, weak 
molecular bond formations occur between the NLS peptides and the plasmids. These are stable 
enough to yield a sufficient tracing effect.  
 
                                   
                        
Fig 15. Schematic Diagram of the Plasmid Backbone Used for Injections of A1 Myotubes  
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This vector uses a CMV promoter to force expression of the reporter-gene of interest. Previous independent studies 
revealed that a CMV promoter is sufficient for expression in A1 myotubes. The H2B-YFP-fusion-construct was 
cloned into the multiple cloning site (MCS) located between the promoter and the reporter gene. The obtained H2B-
YFP fusion protein traced the nuclei of the injected A1 myotubes. The same backbone but with a red fluorescence 
protein (RFP) as the reporter gene, served to stain the cytoplasm of the injected A1 myotubes. 
 
6.3.3 Microinjections of A1 myotubes 
 
Both tracing techniques (either with high molecular dextran or with the plasmids) were operated 
in the same way. An Eppendorf Femtojet (Eppendorf AG) in combination with an Eppendorf 
Injectman (Eppendorf AG) was used for injections. The injections had to be done outside the 
incubator, resulting in a temporal limitation of 30 minutes per plate and injection.  
The actual injections were carried out with Sterile Femtotips II (Eppendorf). Back pressure 
between 30 and 40 hPa were sufficient to load the myotubes with approximately 750-1000 
plasmid-copies/time.  
Microinjections were done on A1 myotubes. For that purpose A1 myoblasts were seeded in 35 
mm dishes coated with fibronectin and gelatine (as described previously). Furthermore, a grid 
was scored to the bottom of the dish to avoid of myotubes becoming too big. Confluent cells 
were induced to differentiate (see above) and microinjections were performed five days 
afterwards. 
 
Subsequent to the injections cells were left to recover for one hour, after which the medium was 
changed. Regular differentiation medium was used, due to the fact that the myotubes were not to 
be isolated. Adjacent incubations were performed with TSA concentrations ranging from 10 
ng/ml to 150 ng/ml. After a period of 72 hours cells were fixed for five minutes at RT by adding 
4% paraformaldehyde (PFA) yielding in a final concentration of 2% PFA. Cells were rinsed once 
with 1xPBS and stored in PBS at 4˚C until further analysis. 
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6.4 Animal work 
 
All experiments were carried out according to European Community and local ethics committee 
guidelines. Furthermore, all animal experiments were performed either by Jamie Morrison or 
under his supervision. Adult red–spotted newts, Notophthalmus viridescens viridescens, were 
supplied by Charles Sullivan & Co (Nashville, TN, USA). Newts were kept in watertanks in a 
humidified room at 15- 20˚C. 
 
6.4.1 Forelimb Amputation 
 
Newts were anesthetized by placing them in an aqueous solution of 0.1% ethyl 3- aminobenzoate 
methanesulfonate salt (Tricaine) (Sigma-Aldrich) for 15 minutes. Forelimbs were amputated by 
cutting just proximal to the elbow and the soft tissue was pushed up to expose the bone. The bone 
and soft tissue were trimmed to produce a flat amputation surface. Animals were left to recover 
overnight in an aqueous solution of 0.5% sulfamerazine  (Sigma-Aldrich) before being placed 
back into a 25˚C water tank. At specified time-points, the regenerating limbs were harvested after 
anesthetization. 
 
6.4.2 Tissue preparation for cryosections 
 
Initial procedures were the same as by forelimb amputations (see above).  
Still anesthetized newts were sacrificed by decapitation. Harvested blastemas were embedded in 
Gum Tragacanth (Sigma-Aldrich). Mounted blastemas were prefrozen in liquid nitrogen-frozen 
isopentane (VWR) for 5 to 10 seconds. Subsequently the blastemas were transferred to liquid 
nitrogen and stored afterwards at -80˚C. 
 
6.4.3 Tissue slicing 
 
Blastemas stored at -80˚C were transferred to the cryostat (Microtome Cryostat Cryo-Star 
HM560M from Microm) in boxes with dry-ice. The cryostat was pre-cooled to -20˚C. Serial 
sections of 6 µm thickness were produced. These sections were fixed on glass slides (SuperFrost 
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® Plus slides from Menzel Gmbh) that had already been prepared with a positive charged 
surface. This was sufficient for preliminary fixation. 
Tissue sections were stored at -80˚C until further usage. 
 
6.4.4 Immunohistochemistry 
 
Blastema tissue sections (see above) were fixed in 4% PFA for 5 minutes at RT followed by a 
three times washing step in PBS for 5 minutes. Afterwards, slides were incubated in 2M HCl plus 
0.5% Triton X-100 (Sigma-Aldrich) for 15 minutes at 37˚C. This was followed by 10 minutes 
incubation in 0.1M Na2B4O7 at RT to neutralise HCl. Subsequently, sections were rinsed in PBS 3 
times for 5 minutes each. Staining was continued by blocking for 1 hour at RT. The blocking 
buffer consisted of 5% goat serum (DakoCytomation), 3% BSA (Sigma-Aldrich) and 0.1% 
Triton X-100 (Sigma-Aldrich) diluted in PBS. Afterwards, sections were rinsed once in PBS. As 
primary antibodies rabbit polyclonal anti-Histone H3 di-methylated K9 (ab7312) (Abcam) and a 
rabbit polyclonal anti-Histone H3 tri-methylated K9 (ab8898) (Abcam) were used. Primary 
antibodies were diluted 1/5000 in blocking buffer (see above) and incubated at 4˚C over night. 
Rinsing with PBS for 5 minutes 3 times each followed. For secondary antibody staining a goat 
anti-rabbit Alexa Fluor 488 antibody was used as usual (see previously). Again this antibody was 
diluted in blocking buffer (see above) to a concentration of 1/400. Secondary antibody incubation 
was done for 1 hour at RT. Three washes in PBS for 5 minutes followed. Next, the preparations 
were DAPI (Sigma-Aldrich) stained (DAPI 1/100 in PBS) for 5 minutes at RT and washed once 
more in PBS for five minutes. Finally, sections were mounted with fluorescent mounting medium 
(DakoCytomation) containing additional 100 ng/ml DAPI (Sigma-Aldrich). 
 
Sections were stored at 4˚C. 
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6.5 Microscopy 
 
6.5.1 Cell- and tissue section microscopy 
 
Fixed and immunocytochemistry stained cells were analysed by using an inverted Axioplan 2 
microscope (Carl Zeiss MicroImaging, Inc.). Phase contrast and fluorescence imaging 
corresponding to the secondary antibody was used.  
Most pictures were taken from myotubes in the centres of wells, as usually an accumulation 
could be observed after purification. 
 
Tissue sections, fixed and stained on glass slides, were analysed under an Axioplan 2 upright 
microscope (Carl Zeiss MicroImaging, Inc.). 
 
6.5.2 Time-lapse microscopy 
 
Time-lapse imaging microscopy was done with an inverted Axioplan 2 microscope (Carl Zeiss 
MicroImaging, Inc.). The microscope was equipped with a motorized stage. Further 
modifications of the microscope were an incubation chamber in combination with a CO2 
controller and a humidifier to provide a controlled environment. Cells in a 35 mm culture dish 
were placed in a dish holder with adjustable temperature on the stage. In this way, conditions 
compared to an incubator could be achieved.  
Unfortunately, the initial time-lapse microscopy series had to be done with an alternative 
medium. This was due to the fact that the CO2 controller was not calibrated at that time. 
Thus, for the initial experiment a different incubator medium based on the L15 medium for 
unstable CO2 conditions was used, until the CO2 controller of the incubator was calibrated. 
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Medium for time-lapse microscopy with atmospheric CO2 conditions 
L15 (Gibco) (dissolved D (+) glucose to 4500mg/l)  96% 
Horse serum (Gibco) 1% 
Sodium pyruvate 1% 
Penicillin/Streptomycin (Gibco) 1% 
GlutaMAX I (100×) (Gibco) 1% 
 
Phase contrast images were sequentially acquired through an integrated camera. Serial images 
were captured at each predefined stage position and focus plane on the dish every hour through a 
10x or 20x objective, respectively. Limitations in the number of captured myotubes arose from 
the memory of the associated computer. 
 
Isolated myotubes were kept in conditioned differentiation medium to recover over night. 
Directly before time-lapse microscopy the medium was changed to adjusted L15 medium (see 
above) or to fresh conditioned differentiation medium containing TSA (see previously). The cells 
were followed for a period of 72 hours. Image sequences were created from each stage position 
and analysed. 
 
6.5.3 Analysis of images 
 
All images taken during the time of the thesis were analysed using an Improvision Openlab 3.1.7 
software (Improvision Ltd.). The images and image frames from the sequences were archived and 
further processed in Adobe Photoshop 7.0. 
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